¥È¥Ã¥×¥Ú¡¼¥¸¤Ø¤â¤É¤ë ¤É¤³¤«¡Ê³¤³°¤«¤é¡©¡Ë¤Î¥¢¥Û¤¬ÊѤʥê¥ó¥¯¤ò¤Ï¤Ã¤Æ¤¤Æ¤¤¤Þ¤¹¡£¤ª¤«¤·¤Ê¥ê¥ó¥¯¤Ï·è¤·¤Æ¥¯¥ê¥Ã¥¯¤·¤Ê¤¤¤Ç¤¯¤À¤µ¤¤¡£ ÀŲ¬ÉÂÍý°å²ñ Shizuoka Pathologist Seminar(SPS)¤ÎWhat's New †ÀŲ¬ÉÂÍý°å²ñ¤Î²ñ°÷¤Î¤«¤¿¤Çvirtual slide¤ò¤ß¤ë¤¿¤á¤ÎID, password¤¬É¬ÍפÊÊý¤Ï¥á¡¼¥ë¤òwikipathologica@gmail.com¤Þ¤Ç¤´Á÷ÉÕ¤¯¤À¤µ¤¤¡£ÀÞ¤êÊÖ¤·Ï¢Íí¤¤¤¿¤·¤Þ¤¹¡£ CONTENTS †
ÀŲ¬ÉÂÍý°å²ñ¡¡Shizuoka Pathologist Seminar(SPS) †ÀŲ¬ÉÂÍý°å²ñ¤Ï4̾¤ÎÉÂÍý°å¤Ë¤è¤ê1976ǯ¤Ë·ëÀ®¤µ¤ì¤Æ°ÊÍè273²ó¤Î¾ÉÎ㸡Ƥ²ñ¤ò¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡¥1985ǯ¤«¤é¤Ï´ØÅìÆîÉôÃ϶è¤ÎÉÂÍý°å¤È¶¦Æ±¤ÇSPS¾ëÆîÉÂÍý½¸Ã̲ñ¤ò³«ºÅ¤¹¤ë¤è¤¦¤Ë¤Ê¤ê¤Þ¤·¤¿¡¥¸½ºß¤Þ¤ÇÌó1480Îã¤Îŵ·¿Î㡤µ©¾¯Îã¤Î¸¡Æ¤¤ò¹Ô¤Ã¤Æ¤¤¤Þ¤¹¡¥ SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø ¡Ê·É¾Îά¡Ë Âè276²ó¡¡ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2019ǯ8·î31Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡Åì´Û 11F¡¡C²ñµÄ¼¼ 1.¡Ö´Î¼ðáî¤Î1Îã¡×
2.¡ÖÃÀ´É¼ðáçÀò¤òȼ¤¦Å¾°ÜÀ´Î¼ðáç¤â¤·¤¯¤Ï¸¶È¯À´Î´â¤¬µ¿¤ï¤ì¤¿´Î¼ðáç¤Î£±Îã¡×
3.¡Öç¹¼ðáç¤Î°ìÎã¡×
4.¡Ö´ããݲ¼¿À·Ð¼ðáî¤Î£±Îã¡×
5.¡Ö¿ÇÃǤޤǤË2¤«·î¤òÍפ·¤¿Ç߯ÇÀ°ß±ê¤Î1Îã¡×
6.¡Ö¤Þ¤ì¤ÊÂçIJ¥Ý¥ê¡¼¥×¤Î1Îã¡×
7.¡Ö¤Þ¤ì¤ÊÂçIJ´â¤Î1Îã¡×
ÆÃÊֱ̹é¡ÖÄÉÅé¡¡¼¼¡¡ÇîÇ·ÀèÀ¸¤ò¼Å¤ó¤Ç¡×
Âè275²ó¡¡ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2019ǯ6·î22Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡Åì´Û 11F¡¡C²ñµÄ¼¼ 1.¡ÖÍñÁã seromucinous borderline tumor ¤Ë¹çÊ»¤·¤¿ leiomyomatosis in pelvic lymph ¡¡node¡×--Leiomyomatosis in the pelvic lymph nodes complicated with ovarian seroumucinous borderline tumor
2.¡Ö²èÁüŪ¤Ë¤âÁÈ¿¥³ØÅª¤Ë¤â¿ÇÃǤ¬ÍưפǤʤ«¤Ã¤¿»ÒµÜÉÂÊÑ¡×--Adenomyoma of the uterus
3.¡Ö°ßÇ´Ëì²¼ÉÂÊѤÎ1Îã¡×--Eosinophilic granuloma associated with chronic anisakiasis
4.¡ÖÅüǢɴµ¼Ô¤ËȯÀ¸¤·¤¿Ê¢Éô¼ðáî¤Î1Îã¡×--Insulin ball; iatrogenic localized insulin-derived amyloidosis
5.¡ÖÆÍÁ³»àÎã¡Ê¥¤¥ó¥Õ¥ë¥¨¥ó¥¶´¶À÷¡Ë£¸ºÐ ÃË»ù¡×--Sudden death associated with Influenza B virus infection
6.¡Öç¯æù´â¤¬µ¿¤ï¤ì·ÐÇ¢Æ»Åªç¯æù¼ðáçÀÚ½ü½Ñ¤¬»Ü¹Ô¤µ¤ì¤¿°ìÎã¡×--Urinary schistosomiasis (bilharzia)
7.¡Öº¸Àå¼ðáç¤Î°ìÎã¡×--Basaloid squamous cell carcinoma of the left side of the tongue
8.¡ÖÇżïÀÂÓ¾õá׿¾¤Ë¤è¤ë·à¾É´Î±ê¤¬µ¿¤ï¤ì¤¿£±Îã¡×--Systemic varicella-zoster virus infection after chemotherapy against post-transplant lymphoproliferative disorder
Âè273²ó ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2019ǯ2·î9Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡À¾´Û12F, ¹ÖƲ 1. ·ëÀáÀ¹Å²½¾Éµ¿¤¤¾ÉÎã¤Î¿Õ¼ðáç¤Î1Îã¡¡39ºÐ½÷À--Renal cell carcinoma with smooth muscle (or leiomyomatous) stroma(WHO̤¼ýºÜ)
2. ±ê¾ÉÀÀ®Ê¬¤òȼ¤¦´Î·ì´É¶Ú»éËüð¤Î°ìÎã¡¡50ºÐÃËÀ--Hepatic angiomyolipoma with an inflammatory component
3. ³°±¢ÉôÈé²¼¼ðáç¤Î°ìÎã¡Ê¤½¤Î2)¡¡45ºÐ½÷À--Cellular angiofibroma (?)
4. ¹ÈϤʿ»½á¤ò¼¨¤·¤¿Æý´â¤Î°ìÎã 63ºÐ½÷À--Acinic cell carcinoma of the breast
5. Charcot-Leyden ·ë¾½¤òȼ¤Ã¤¿¹¥»ÀÀÆù²ê¼ð¤Î2Î㤪¤è¤Óµ¤´É»ÙÓé¤Î1Îã--extracellular trap cell death
6. ±¦Â¦Æ¬ÉôÈéÉæ¼ðáç 83ºÐ½÷À--primary cutaneous anaplastic large cell lymphoma, ALK-negative.
7. Ê¢¹ÐÆâ¼ðáç¤Î°ìÎã 20ºÐÂå½÷À--yolk sac tumor of the peritoneum
8. KITÌîÀ¸·¿GIST¤Î°ìÎã¡¡69ºÐÃËÀ-- Carney-Stratakis syndrome (GIST and paraganglioma, SDHB-mutant)
9. Ãæ°öƬ¼ðáç¤Î°ì¼ê½ÑÎã¡¡56ºÐÃËÀ--HPV-unrelated multiphenotypic carcinoma (?)
Âè272²ó ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2018ǯ12·î8Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡À¾´Û12F, ¹ÖƲ 1. ¡ÖÁÈ¿¥·¿¤¬ÌäÂê¤È¤Ê¤Ã¤¿¼ãǯÀ»ÒµÜÂδâ¤Î°ìÎã¡×20ºÐÂå½÷À--Endometrioid carcinoma with corded and hyalinized pattern
2. ¡ÖÆýÁ£¼ðáç¤Î°ìÎã¡×78ºÐ½÷À--microglandular adenosis with carcinoma
3. ¡Ö³°±¢ÉôÈé²¼¼ðáç¤Î°ìÎã¡×45ºÐ½÷À-- myoepithelioma
4. ¡Ö¥¿¥ó¥Ñ¥¯Ï³½ÐÀ°ßIJ¾É¤Î°ìÎã¡× 50ºÐÂåÃËÀ---Strongyloidiasis (ʵÀþÃî¾É)
5.¡ÖÂçÆ°Ì®²òÎ¥¤ÎÉÂÍý¡×---Aortic dissection
6. ¡Ö½ÑÁ°¿ÇÃÇ¤ËÆñ½Â¤·¤¿½½Æó»ØÄ²°ß·¿Á£´â¡×63ºÐÃËÀ--Duodenal adenocarcinoma, gastric type
Âè271²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †Âè271²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï SPS-¾ëÆîÉÂÍý¹çƱº©Ã̲ñ¤Ë¤Ê¤ê¤Þ¤¹ 2018ǯ10·î6Æü¡ÊÅÚ¡Ë ÅìµþÅÔÉÊÀî¶è´ú¤ÎÂæ ¾¼ÏÂÂç³ØÉ±¡Î×¾²¹ÖƲ Âè270²ó ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2018ǯ8·î25Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡Åì´Û11F, C²ñµÄ¼¼ 1.¡Ö°ß¼ðáç¤Î°ìÎã¡×---Gastric adenocarcinoma of funds gland type, chief cell predominant type
2.¡ÖIJÊĺɤò·«¤êÊÖ¤¹£±Îã¡×---Mesenteric phlebosclerosis
3.¡Ö¥¢¥ë¥³¡¼¥ëÀ´Î¹ÅÊѤˤߤé¤ì¤¿´Î·ëÀáÀÉÂÊѤΣ±Îã¡×---Serum amyloid A-positive hepatocellular neoplasm/nodule arising in alcoholic liver cirrhosis
4.¡ÖSerous endometrial intraepithelial carcinoma ¤Î°ìÎã¡×---Serous endometrial intraepithelial carcinoma
5.¡ÖÁá´ü°ß´â¤Î³ÔÀ¶¥ê¥ó¥ÑÀá¤Çȯ¸«¤µ¤ì¤¿¶öȯÉÂÊѤΣ±Îã¡×---Incidental well differentiated liposarcoma around the dissected lymph nodes #4sb
6.¡ÖǾ¼ðáç(DNT), 11ºÐ ÃË»ù¡×---Dysembrioplastic neuroepithelial tumor (DNT), non-specific and diffuse form
7.¡Ö½Ä³Ö¼ðáç¤Î£±Îã¡×---Thymic MALT lymphoma
8.¡Ö¹Ã¾õÁ£¼ðáç¤Î°ìÎã¡×---TTF-1-positive Thymoma, type AB, arising from ectopic thymus
9.¡ÖƬ³¸Äì Focal Haematopoietic Hyperplasia ¤Î°ìÎã¡×---Focal hematopoietic hyperplasia (Reconversion from yellow to red marrow) of the calvarium
¡ÚÏ¢Íí»ö¹à¡Û
²ñ½ªÎ»¸å¡¡¤Ò¤³¤Í¤ÇǼÎòñ Âè269²ó ÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2018ǯ6·î9Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡Åì´Û11F, C²ñµÄ¼¼ 1. ¡ÖÊ¢Ëì¼ðáç¤Î1Îã¡×---undifferenciated (pleomorphic) sarcoma/ dedifferentiated liposarcoma
2. ¡ÖǾ¼ðáç¤Î°ìÎã¡×--subependymoma with intraventricular hemorrhage ¾ÉÎã¤Î¥Ú¡¼¥¸?
3.¡¡¡Ö¿©Æ»¼ðáç¤Î°ìÎã¡×--Lymphoepithelial carcinoma of the esophagus
4.¡¡¡Ö¹Ã¾õÁ£´â¤Î°ì¼ê½ÑÎã¡×--Warthin-like papillary carcinoma+ papillary carcinoma
5.¡¡¡ÖßÉ˦À¥ê¥ó¥Ñ¼ð? ¥Þ¥¸¤Ã¤¹¤«.- Follicular lymphoma with diffuse growth pattern¤Î2¾ÉÎã¡×
6.¡¡¡Ö¿Õ¡¸¶È¯ Ewing sarcoma/ primitive neuroectodermal tumor¤Î°ìÎã¡×
7.¡¡¡Ö´Îǹ˦À¼ðáç¤Î°ìÎã¡×--undifferentiated sarcoma(embryonal sarcoma) of the liver
Âè268²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2018ǯ4·î7Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡Åì´Û11F, C²ñµÄ¼¼ 1.¡Ö°ßÇ´Ëì²¼¼ðáç¤Î£±Îã¡×Gastrointestinal Glomus tumor
2.¡ÖLow grade neuroendocrine tumor ¤¬µ¿¤ï¤ì¤¿»ÒµÜ¼ðáç¤Î°ìÎã¡×¡Ëuterine tumor resembling ovarian sex-cord tumor
3.¡ÖÊ¢ÊÉ·ëÀá¤Î1Îã¡×eosinophilic cellulitis due to Paragonimiasis (Paragoinimus skrjabini), abdominal wall
4.¡Ö´â¼ðÀ®Ê¬¤È¤·¤ÆÛùÍ»²ò·¿Ù¨Ê¿¾åÈé´â¤ÈÂñÕÁ£Æ³´É´â¤¬È¯À¸¤·¤¿Â¿·ÁÁ£¼ðͳÍè´â¤Î°ìÎã¡×Carinoma ex pleomorphic adenoma (CXPA) composed of both acantholytic squamous cell carcinoma (ASCC) and salivary duct carcinoma (SDC) components
5.¡ÖÆÍÁ³»à¤·¤¿Ã˻Ҿ®³ØÀ¸¤Î£±Ë¶¸¡Îã¡×¡¡Arrhythmogenic right ventricular cardiomyopathy (ARVC)
6.¡ÖIgD multiple myeloma ¤Î°ìÎã¡×CD20-positive IgD myeloma
7.¡Ö°ß´âÆù¼ð¤Î°ìÎã¡× Carcinosarcoma of the stomach; AFP-producing adenocarcinoma with enteroblastic differentiation and sarcomatoid change (AFP, GPC3, SALL4, Claudin-6¤¬ÂÛ»ùÀ®Ê¬¤ÎÌÈÀ÷¤ËÍÍÑ)
8.¡Ö¿´º¸Ë¼Æâ¼ðáç¤Î£±Îã¡×Cardiac osteosarcoma of the left atrium; extraskeletal osteosarcoma
Âè267²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2018ǯ1·î27Æü(ÅÚ) 13:30-17:00 ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡À¾´Û11FÂè°ì²ñµÄ¼¼ 1. Ž¢¥¹¥Æ¥í¥¤¥É¼£ÎŸå¤Î¶»Á£¼ðáç¤Î1Î㎣¡¡thymoma
2. Ž¢½ÑÃæ¿×®¿ÇÃǤ¬º¤Æñ¤Ç¤¢¤Ã¤¿ÇÙ¼ðáç¤Î1Î㎣¡¡PEComa of the lung
3. Ž¢´ÎÆâÃÀ´É¼ðáç¤Î1Î㎣¡¡IPBN
4. Ž¢¿ÇÃǤ˶ìθ¤·¤¿ÇÙ·ëÀáÀÉÂÊѤÎ1Î㎣ sarcomatoid mesothelioma
5. Ž¢°ßÀ¸¸¡¤«¤é¿»½áÀ¾®Íմ⤬¸¡½Ð¤µ¤ì¤¿3Î㎣¡¡lobular carcinoma of the breast metastasized to the stomach, report of three cases.
6. Ž¢²¼³Ü¥ê¥ó¥ÑÀá¼ðáç¤Î1Î㎣¡¡blastic plasmacytoid dendritic cell neoplasum
7. Ž¢Ç®Ãæ¾É¤Î1˶¸¡Î㎣¡¡
²ñ½ªÎ»¸å¤Ë¡¡Ž¢¤Ò¤³¤ÍŽ£¤Ë¤ª¤¤¤Æ¿·Ç¯²ñ Âè266²óÀŲ¬ÉÂÍý°å²ñ(SPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹) †Âè266²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï SPS-¾ëÆîÉÂÍý¹çƱº©Ã̲ñ¤Ë¤Ê¤ê¤Þ¤¹ 2017ǯ11·î11Æü¡ÊÅÚ¡Ë¡¡ÀŲ¬¸©»°Åç»Ô »°Åç»Ôʸ²½²ñ´ÛÂè2²ñµÄ¼¼ Âè265²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2017ǯ8·î26Æü(ÅÚ) ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡Åì´Û11³¬C²ñµÄ¼¼ 1.¡ÖÆñ¼£À²¼Î¡¤Î£±Îã¡×-- ¥é¥ó¥Ö¥ëÊÜÌÓÀþÃî´¶À÷¾É/ ¾®Ä²
2.¡Ö²¼ÉôÃÀ´É¼ðáç¤Î1Îã¡×--undifferentiated carcinoma with osteoclast-like giant cells, bile duct
3.¡ÖCrohnɤǾ®Ä²ÀÚ½ü¤·¤¿1Îã¡×-- poorly diff. adenocarcinoma arising in inflammatory fibroid polyp of the patient having Chron disease
4.¡Ö44ºÐ½÷À¤ÎǢƻ¼ðáç¡×--Clear cell adenocarcinoma of urethra in woman
5.¡Öž°ÜÀÇÙ¼ðáç¤Î°ìÎã¡×---ameloblastoma metastasized to the lung
6.¡ÖCOPA¾É¸õ·²¡Á²È²À´Ö¼ÁÀÇÙ±ê¤Î˶¸¡Îã¡×---COPA syndrome
7.¡Ö¿ÇÃÇ¤ËÆñ½Â¤·¤¿Èé²¼¼ðáç¤Î°ìÎã¡×--malignant mixed tumor of the skin
²ñ½ªÎ»¸å¡¡¡Ö¤Ò¤³¤Í¡×¤Ë¤ª¤¤¤ÆÇ¼Îòñ(¤Þ¤¿¡¢»²²Ã¤Ç¤¤Ê¤«¤Ã¤¿.) Âè264²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2017ǯ6·î24Æü(ÅÚ) ÀŲ¬»Ô, ÀŲ¬»ÔΩɱ¡À¾´Û11³¬²ñµÄ¼¼ 1.¡ÖÂçÂÜÈé²¼¼ðáî¤Î£±Îã¡×-- hybrid schwannoma/ perineuroma
2.¡ÖDM¡¡dermopathy ¤Î1Îã¡×
3.¡Ö¼£ÎŤ˶ìθ¤·¤¿¿Õ¼ðáî¤Î1Îã¡×-- maracoplakia
4.¡Ö»ÒµÜÂÎÉô¤Î٨ʿ¾åÈé²½À¸¤òȼ¤¦ÎàÆâËìÁ£´â¤Î°ìÎã¡×
5.¡ÖCD45/leukocyte common antigen(LCA)ÍÛÀ thymic poorly diff. squamous cell carcinoma ¤Î2¾ÉÎã-¼ðáçºÙ˦¤ÎͳÍè¤ò¹Í¤¨¤Æ¤ß¤Þ¤·¤¿¡×
6.¡ÖIgG4´ØÏ¢¶»ÉôÂçÆ°Ì®±ê¤¬¹Í¤¨¤é¤ì¤¿¾å¹ÔµÝÉôÂçÆ°Ì®áî¤Î£±Îã¡×
7.¡Ö¾®Ç¾¼ðáç¤Î£±Îã¡×--Lhermitte-Duclos disease (Dysplastic cerebellar gangliocytoma)
¡ÚÏ¢Íí»ö¹à¡Û ¡¦¡Ö¾ëÆîÉÂÍý-SPS ¹çƱº©Ã̲ñ¡×¤Î¤ªÃΤ餻 ¡¦¡ÖÊ¿À®29ǯÅÙÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÀìÌçÉÂÍý°åÍÜÀ®¸¦½¤²ñ¡×¤Î¤ªÃΤ餻 ¡¦¤½¤Î¾ Âè263²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2017ǯ4·î15Æü(ÅÚ) 13:30-17:00 ÀŲ¬Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¡Ö¤¢¤¶¤ì¤¢¡×4³¬ÆÃÊ̲ñµÄ¼¼ 1. ¡Ö´Î¼ðáî¤ÎÀ¸¸¡¤Î°ìÎã¡×-- epithelioid hemangioendothelioma
2.¡¡¡Ö´Î¼ðáî¤Î°ìÎã¡×--epithelioid hemangioendothelioma
3.¡¡¡ÖÇÙ¼ðáç¤Î°ì˶¸¡Îã¡×--pulmonary artery intimal sarcoma
4.¡¡¡Ö·«¤êÊÖ¤¹°ßÄÙá礬¸¶°ø¤È»×¤ï¤ì¤Æ¤¤¤¿°ßÍ©ÌçÉô¶¹ºõ¤Î°ìÎã¡×--adenocarcinoma arising in ectopic pancreas
5.¡¡¡Ö¼ª²¼Á£¼ðáç¤Î°ìÎã¡×--intraductal carcinoma, low-grade (WHO2017)
6.¡¡¡ÖÆÃ°Û¤ÊÁÈ¿¥Áü(Ç´±Õ»ºÀ¸Áü)¤òÄ褷¤¿¹Ã¾õÁ£´â¤Î°ìÎã¡×--papillary carcinoma, variant
7.¡¡¡ÖÇÙ¼ðáç¤È¤·¤ÆÀÚ½ü¤µ¤ì¤¿Èó¼ðáçÀÇÙÉÂÊÑ¡×--peribronchial metaplasia and extensive (alveolar) squamous metaplasia
8.¡¡¡ÖÀ¸¸¡¤Ç²½À¸´â¤¬µ¿¤ï¤ì¤¿ÆýÁ£¼ðáç¤Î°ìÎã¡×--DCIS and giant cell tumor(GCT)
9. ¡Ö¶õIJ¼ðáç¤Î°ìÎã¡×-- gangliocytic paraganglioma of the jejunum
10. ¡Ö¿Õ¼ðáç¤Î°ìÎã¡×--angiomyolipoma with predominantly smooth muscle differentiation and renal cell carcinoma
²ñ½ªÎ»¸åÀŲ¬»Ô¡Ö²Ø»Ò¤Î²Ö ̵°Ã¡×¤Ç¿·¿Í´¿·Þ²ñ.¡¡¿·¿ÍÉÂÍýÀì¹¶°å¡¡4¿Í Âè262²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2017ǯ1·î28Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡¡¡Åì´Û11³¬¡¡C²ñµÄ¼¼ 1. ¡ÖÇÙ²á¸í¼ðÀ®Ê¬¤òȼ¤¤Â¿·ÁÆù¼ð¤ÎÁü¤ò¼¨¤·¤¿ÇÙ¼ðáç¤Î1²ò˶Îã¡×-- malignant mesenchymoma¤¬Ì¾¾Î¤È¤·¤ÆÅ¬ÀڤǤϡ£
2.¡¡¡Ö°ßSMTÍͼðáç¤Î°ì˶¸¡Îã¡×--epithelioid hemangiosarcoma
3.¡¡¡Ö¶â¤Î»å¤¬ÇÙÆ°Ì®¤ËÌÂÆþ¤·¤¿°ìÎã¡×
4. ¡Ö´Î³°ÃÀ´É¼ðáî¤Î2Îã¡×
5.¡¡¡Ötubular adenoma of the breast¡×--pseudomembranous colitis
6.¡¡¡ÖIJ´É¥¹¥Ô¥í¥Ø¡¼¥¿¾É¤Î2¾ÉÎã¡×
7.¡¡¡Öº®¹çɽ¸½·¿µÞÀÇò·ìÉÂ, MPAL with t(9;22)(q34;q11.2); BCR-ABL1¤Î°ìÎã¡×
8.¡¡¡ÖºÇ¶á·Ð¸³¤·¤¿¶½Ì£¤¢¤ë3Îã¡×-- phosphaturic mesenchymal tumor(CD56,SSTR2¤¬ÍÛÀ¤Ë¤Ê¤êFGF23ÌȱÖÀ÷¿§¤Ç³Î¿Ç), IgG4-rellated lymphadenopathy, Eccrine angiomatous hamartoma
Âè261²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2016ǯ12·î3Æü(ÅÚ¡ËÀŲ¬»ÔΩÀجɱ¡¡Ê11³¬ C²ñµÄ¼¼¡Ë 1.¡ÖEpithelioid sarcoma ¤È¿ÇÃǤµ¤ì¤¿¾ÉÎã¤ÎÀ¸¸¡»þ¿ÇÃÇ¡×
2.¡ÖÊø²õ¤·¤¿ÆýÁ£¼ðáç¤Î£±Îã¡×
3.¡ÖËýÀÌôºÞÀ´Î±ê¤Î£±Îã¡×
4.¡ÖǾ¼ðáç¤Î£±Îã¡¡£²ºÐ£¸¥õ·î ÃË»ù¡×
5.¡ÖBronchioloalveolar tumor with two cell growth pattern, hyperplasia or neoplasia¡×
6.¡Ö°ßÇ´Ëì²¼¼ðáç¤Î£±Îã¡×
7.¡Ö¹Ã¾õÁ£¼ðáç¡¡91ºÐ ½÷À¡×
8.¡ÖÉÔÌÀÇ®¡¢Ê¢¹Ð¥ê¥ó¥ÑÀá¼ðÂç¡¢Æù²ê¼ðÍÍÉÂÊѤ¬¤ß¤é¤ì¤¿ MCTD ¾ÉÎã¡×
9.¡ÖEwing-like sarcoma ¤Î£²Îã¡×
SPS ½ªÎ»¸å¤Ë¡Ö¤È¤ß°æ¡×¤Ç˺ǯ²ñ³«ºÅ¡£ Âè260²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †Âè260²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï SPS-¾ëÆîÉÂÍý¹çƱº©Ã̲ñ¤Ç¤¹ 2016ǯ10·î23Æü¡ÊÆü¡Ë¡¡ÅìµþÅÔ¹¾Åì¶è˽§5-1-38 ¾¼ÏÂÂç³Ø¹¾Åì˽§É±¡£¹³¬¹ÖƲ Âè259²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS) †2016ǯ9·î3Æü(ÅÚ) 13:30-17:00 ÀŲ¬¸©Áí¹ç¼Ò²ñÊ¡»ã²ñ´Û¥·¥º¥¦¥§¥ë103²ñµÄ¼¼ 1. ¡Öµ¤´É»Ù¼ðáç¤Î°ìÎã¡×-- gangliocytic paraganglioma
2.¡¡¡Ö´ÕÊ̤˶ìθ¤·¤¿ÆðÉô¼ðáç¤Î°ìÎã¡×--epithelioid sarcoma
3.¡¡¡Ö·ì±ÕÁý¿£¼À´µ¤¬µ¿¤ï¤ì¤¿ÂçIJ±ê¤Î°ì˶¸¡Îã¡×--pseudomembranous colitis
4.¡¡¡Ö´ñ°Û¤Ê°ßÉÂÊѤΰìÎã¡×--Massive gastric polyposis with SMAD4 mutation
5.¡¡¡Ö»ÒµÜÆâËì¾É¤òȼ¤¦Äã°Û·¿ÅÙÃî¿âÇ´±ÕÀ¼ðáç¤Î°ìÎã¡×
6.¡¡¡Ö¾åÍÕÍ¥°Ì·¿ÇÙÀþ°Ý¾É¤Î2¾ÉÎã¡×--ÆÃȯÀ¾åÍÕÍ¥°Ì·¿ÇÙÀþ°Ý¾É(ÌÖëÉÂ)
7.¡¡¡Ö¾®Ä²¼ðáç¤Î°ìÎã (³Êó: No253SPS)¡×--Luteinized adult granurosa cell tumor --> steroid cell tumor, NOS
¾ëÆîÉÂÍý-SPS ¹çƱº©Ã̲ñ: 10·î23Æü(Æü) 11-15»þ¡¡¾¼ÏÂÂç³Ø¹¾Åì˽§É±¡9³¬¹ÖƲ (À¤ÏÿÍ:¶åÅç̦¼ùÀèÀ¸) Âè258²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2016ǯ6·î25Æü(ÅÚ)13¡§30¡Ý17¡§00 ÀŲ¬»ÔΩɱ¡Åì´Û 11³¬C²ñµÄ¼¼ 1. ¡ÖÀèÅ·À¿ȯ½½Æó»ØÄ²Êĺ¿¾É¤Î1Îã¡×
2. ¡ÖǾ¼ðáç¤Î1Îã(5ºÐÃË»ù)¡×-- undifferentiated sarcoma
3. ¡Ö2ºÐ»ù¤ÎÂçÂÜÉô¤ËȯÀ¸¤·¤¿Èé²¼¼ðáî¤Î1Îã¡×--lipofibromatosis
4. ¡Ö¿ÕⳤËȯÀ¸¤·¤¿å°ÌÓÁ£¼ð¤Î1Îã¡×-- villous adenoma of the pelvis
5. ¡Öº¸¿´¼ªáî(68ºÐ½÷À)¡×
6. ¡ÖÂñÕÁ£Ç¹Ë¦À¼ðáî¤Î1Îã¡×-- low-grade variant of the salivary duct carcinoma
7. ¡Ö¤¢¤ó¥Ñ¥óÍͤβèÁü·ÁÂÖ, Æù´ã·ÁÂÖ¤ò¼¨¤·¤¿ÆýÁ£¼ðáî(60ºÐ½÷À)¡×-- invasive ductal carcinoma with large central acellular zone
²ñ½ªÎ»¸å¡¡¡Ö¤Ò¤³¤Í¡×¤Ë¤ÆÇ¼Îòñ³«ºÅ Âè257²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2016ǯ4·î23Æü(ÅÚ)13¡§30¡Ý17¡§00 ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢¡¡Â¿ÌÜŪ¼Â½¬¼¼¡ÊÃϲ¼£±³¬) 1.¡ÖÃÀǹ¸¶È¯¤Î neuroendocrine carcinoma with adenocarcinoma component ¤Î°ìÎã¡×
2.¡ÖÈéÉæ¼ðáç¤Î1Îã¡×--Dermatofibrosarcoma protuberans with low-grade fibrosarcomatous component
3.¡Öµ¤¶»¤ò·«¤êÊÖ¤·¤ª¤³¤·¤¿Á°³ÛÉô·ì´ÉÆù¼ð¤Î£±Îã¡×--angiosarcoma of the skin metastasized to lung
4.¡ÖÀèÅ·À¹â¥¤¥ó¥¹¥ê¥ó·ì¾É¡Ê£¶¥õ·î½÷»ù¡Ë¡×--Nesidioblastosis, focal form, adenomatous hyperplasia, pancreas
5.¡ÖĹ´üÆ©ÀÏ´µ¼Ô¤ËȯÀ¸¤·¤¿²óIJÀü¹¦¤Î£±Îã¡×--¥Ý¥ê¥¹¥Á¥ì¥ó¥¹¥ë¥Õ¥©¥ó»ÀCaÄÀÃå¤Ë¤è¤ë²óIJÀü¹¦
6.¡ÖÂñÕÁ£Æ³´É´â¤Ë¤ª¤±¤ë¥¢¥ó¥É¥í¥²¥ó¼õÍÆÂΤÎʬ»ÒÉÂÍý³ØÅª¸¡Æ¤¡×
7.¡ÖÃÀǹ±ê¤Î¼ê½Ñ¤Ç¸«¤Ä¤«¤Ã¤¿¥Ý¥ê¡¼¥×ÍÍÉÂÊѤÎ1Îã¡×--carcinosarcoma (¤µ¤é¤Ë¸¡Æ¤¤¬É¬ÍסË
Âè256²óÀŲ¬¸©ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2016ǯ2·î13Æü(ÅÚ) ÀŲ¬»ÔÀŲ¬»ÔΩÀجɱ¡ À¾´Û12F¹ÖƲ 1.¡ÖDeep benign fibrous histiocytoma¤È¿ÇÃǤµ¤ì¤¿2Îã¡×
2. ¡ÖÌçÌ®°µÐ¶¿Ê¾É¤Î1Îã¡×- idiopathic portal hypertention (IPH) [Banti¾É¸õ·²]
3.¡ÖÃî¿â¼ðáî¡×10ºÐÂå½÷»ù - adenocarcinoma in villous adenoma
4.¡Ö¸å½Ä³Ö¤Î¼ðáçÍÍÉÂÊѤȤ·¤ÆÅ¦½Ð¤µ¤ì¤¿¿ñ³°Â¤·ìÁã¤Î1Îã¡×
5.¡Ö¾Ë»Ò²½º÷¾õ¼ðáç¤ÈÆýƬ´â¤ò¹çÊ»¤·¤¿¹Ã¾õÁ£¼ðáç¤Ë¤ª¤±¤ëÉÂÍýÁÈ¿¥³Ø¤ª¤è¤ÓºÙ˦³ØÅª¸¡Æ¤¡×
6.¡ÖÀ¸¸¡¤Çfibromatosis-like metaplastic carcinoma¤òµ¿¤Ã¤¿1Îã, ¤½¤Î¸å¡×Æý˼
7. ´Î¼ðáç¤È¿ȯÇÙ·ì´ÉÉÂÊѤòǧ¤á¤¿1Îã, ¤½¤Î¸å
Âè255²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †1.¡Ö»ÒµÜ¸¶È¯¤Î°À¥ê¥ó¥Ñ¼ð¤È¿ÇÃǤµ¤ì¤¿Ë¶¸¡Îã¡×
2.¡ÖÀ®¿ÍTºÙ˦Çò·ìɤΰì˶¸¡Îã¡Ê79ºÐ¡¦ÃËÀ¡Ë¡×
3.¡Ö±¦¸åƬÍÕ¤ÎǾ¼ðáç¾ÉÎã¡Ê13ºÐ¡¦½÷»Ò¡Ë¡×
4.¡Öº¸¼ª²¼Á£¼ðáç¤Î°ìÎã¡×
5.¡Ö´Î¼ðáç¤È¿ȯÇÙ·ì´ÉÉÂÊѤòǧ¤á¤¿£±¾É¡×
6.¡Ö¿Õ angiomyolipoma with epithelial cysts ¤Î£±¾ÉÎã¡×
7.¡Öç¯æù¤ËȯÀ¸¤·¤¿ÌÀºÙ˦·¿Ç¢Ï©¾åÈé´â¤Î1Îã¡×
8.¡ÖÌó£³Ç¯´Ö Parkinson disease ¤Î¿ÇÃÇ´ð½à¤Ë½¾¤¤²ÃÎÅÃæ¡¢¸íÓëÀÇÙ±ê¤Ç»àË´¡¢Ë¶¸¡¤Ë¤ÆÂçǾÈé¼Á´ðÄì³ËÊÑÀ¾É¡Êcorticobasal degeneration; CBD)¤È¿ÇÃǤµ¤ì¤¿£±¾ÉÎã¡×
Âè254²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †Âè254²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï¾ëÆî-ÀŲ¬ÉÂÍý¹çƱ¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ç¤¹¡£ Âè253²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2015ǯ8·î30Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡À¾´Û12³¬¹ÖƲ 1. ¡Ö¾®Ä²¼ðáç¤Î°ìÎã¡×82ºÐ½÷À¡¡¾®Ä² --- Late metastasis of ovarian luteinized adult granulosa cell tumor
2. ¡Ö¿ÇÃÇ¤ËÆñ½Â¤·¤¿º¸ÆýÁ£¼ðáç¤Î°ìÎã¡×56ºÐ½÷À¡¡Æý˼¡¡--- fibromatosis-like metaplastic carcinoma, suspicious of
3. ¡Ö±¦²¼ÍÕ¤ÎÁÈ¿¥É¸Ëܾå¤Ë13¸Ä¤Î¼ðáçÉÂÊѤ¬Ç§¤á¤é¤ì¤¿ÇÙ¸¶È¯ÀÆýƬ¾õÁ£´â¤ÎÁÈ¿¥È¯À¸¤Ë¤Ä¤¤¤Æ¡×80ºÐÂåÃËÀ~¡¡
4. ¡ÖÂçÆ°Ì®ÊÛ¤ÎÏ·²½¤Ë¤È¤â¤Ê¤¦ÊѲ½¤Ë¤Ä¤¤¤Æ¡×»°±º¹îÉÒ¡¡É;¾°åÂç´ðÁôǸî·ò¹¯²Ê³Ø 5. ¡Ö´¶À÷À¿´ÆâËì±ê¤Î°ì¾ÉÎã¡×---mesothelial/monocystic incidental cardiac excrescences(MICE)
6. ¡ÖMarphan¤Î¿´·ì´ÉÉÂÊÑ¡×---Marphan syndrome
²ñ½ªÎ»¸å¡¡¡Ö¤Ò¤³¤Í¡×¤Ë¤ÆÇ¼Îòñ³«ºÅ Âè252²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2015ǯ5·î30Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔÃ˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢B4 ¿ÌÜŪ¼¼ 1. ¡Ö20ǯ¤«¤±¤ÆÁýÂ礷¤¿ÇÙ¼ðáç¤Î°ìÎã¡×--- malignant solitary fibrou tumor arising in the lung
2. ¡Ö¼«Á³Âà½Ì¤òÍ褿¤·¤¿ÇÙ´â¤Î2¾ÉÎã¡×
3.¡¡¡ÖMacroglobulinemia3¾ÉÎã¤ÎMYD88 L265P mutation¤Ë¤è¤ëÊä½õ¿ÇÃÇ¡×
4.¡¡¡ÖAML¤Ë¤ÆÆþ±¡¸å myeloid sarcoma (leukemia cutis)¤È¿ÇÃǤµ¤ì¹ü¿ñ°Ü¿¢¸åÁ´¿È½ô¡´ï¤ËµÞÀGVHD¤òȯ¾É¤·¤¿1Îã¡×
5.¡¡¡Öº¸ÀºÁã¼ðáç--12ºÐÃË»ù¡×--- mixed germinal cell tumor
6.¡¡¡ÖÍñÁãÌÀºÙ˦¼ðáç¤Î°ìÎã¡×
7.¡¡¡Ö·ÛÉô¼ðáî¤Î°ìÎã¡×---plexiform schwannoma
8.¡¡¡ÖEvans¾É¸õ·²¤¬µ¿¤ï¤ì¤¿¹âÅÙÉÏ·ì¤Î°ìÎã¡×33ºÐÃËÀ
Âè251²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2015ǯ3·î21Æü(ÅÚ) 13:30-17:00 ÀŲ¬»ÔÃ˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢B4 ¿ÌÜŪ¼¼ 1. ÂÛ»ù´ü¤Ëȯ¸«¤µ¤ì¤¿Éû¿Õ¼ðáç¤Î°ìÎã¡¡28dayÃË»ù ȬÌÚ½ÕÆà, Ê¡ÅèËãͳ, ÇϾìÁï, ÉͺêË ¸©Î©¤³¤É¤âɱ¡) neuroblastoma 2. Çò·ìɤ˹çÊ»¤·¤¿¿¿¶Ý´¶À÷¾É¡¡10ºÐ½÷»ù ÉͺêË(ÀŲ¬¸©Î©¤³¤É¤âɱ¡) B lymphoblastic lymphoma and systemic mucormycosis 3. ±¦ÍñÁã¤ËÀ¸¤¸¤¿endometrioid adenocarcinoma with mucinous change¤Î°ìÎã 47ºÐ½÷À¡¡ÂçÀ¾°ìÊ¿, ÎëÌÚĬ¿Í, ¿óâú´»Ò, ¿ú¼½Õɧ, 벬½ñɧ(ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzÊ, ƱÎ×¾²¸¡ºº²Ê, É;¾°åÂç¼ðáçÉÂÍý³Ø) 4. ǢƻÌÀºÙ˦Á£´â¤Î1Îã 40ºÐÂå½÷À Âç·î´²Ïº(À»ÎìÉ;¾É±¡) clear cell adenocarcinoma arising in urethral diverticum 5. Ìô¿¾¤¬µ¿¤ï¤ì¤¿1Îã- áÎáý¾É, 75ºÐÃËÀ¡¡ÇϾìÁï¡ÊÉ;¾°åÂçɱ¡ÉÂÍýÉô) SCABIES¡¡ÈéÉæáÎáý¾É 6. Á´¿ÈÀ¥ê¥ó¥ÑÀá¼ðÂç¡¡50ºÐÂåÃËÀ¡¡ÎëÌÚÀ¿, ¼¼ÇîÇ·, ¿·°æ°ì¼é¡ÊÀŲ¬¸©Î©Áí¹çɱ¡) diffuse large B-cell lymphoma followed by classical Hodgkin lymphoma 7. °ß°À¥ê¥ó¥Ñ¼ð¤¬µ¿¤ï¤ì¤¿1Îã 67ºÐ½÷À ÅÏîµÎï»Ò¡ÊÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼¡Ëlymphomatoid gastropathy Âè250²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2015ǯ1·î24Æü(ÅÚ)¡¡13:30-17:00 ÀŲ¬»ÔΩÀجɱ¡¡¦À¾´Û12³¬¹ÖƲ 1. Ê¢¹ÐÆâ¼ðáî¤Î1Î㡡ȬÌÚ½ÕÆà, Á°Â¿¾¾´î(É;¾°å²ÊÂç³ØÉí°É±¡, ˶¶»Ô̱ɱ¡) Castleman disease + follicular dendritic cell tumor 2. ¿À·ÐÈéÉæ¹õ¿§¾É 10ºÐ½÷À ÉͺêË (ÀŲ¬¸©Î©¤³¤É¤âɱ¡) neuroctaneous melanosis + meningeal melanocytosis/ melanomatosis 3. Á´¿È¥ê¥ó¥ÑÀáž°Ü, Ǿž°Ü¤ò¤¤¿¤·¤¿¸¶È¯ÉÔÌÀ´â¤Î1Îã¡¡ÂçÀ¾°ìÊ¿¤Û¤«(ÈØÅÄ»ÔΩÁí¹çɱ¡, É;¾°åÂç¼ðáçÉÂÍý³Ø¹ÖºÂ) high-grade adenocarcinoma, mixed type of the lt. fallopian tube 4. ÈéÉæ¤Î¿ȯ¥Þ¥Ã¥·¥å¥ë¡¼¥à·¿¼ðáî¤Î1Îã¡¡¼¼ÇîÇ·¤Û¤«(ÀŲ¬¸©Î©Áí¹çɱ¡, É;¾°å²ÊÂçºÆÀ¸¡¦´¶À÷ÉÂÍý³Ø¹ÖºÂ) 5. ¤Þ¤ì¤ÊÁÈ¿¥Áü¤òÄ褷¤¿°ß´â¤ÈÁá´üÂçIJ´â¤È¤Î½ÅÊ£´âÎã ³Þ¸¶ÀµÃˤۤ«(ÀŲ¬ÀÖ½½»úɱ¡, Æ£ÅÄÊÝ·ò±ÒÀ¸Âç³ØÉÂÍý¿ÇÃDzÊ) stomach; tubular adenocarcinoma with sarcomatous differentiation. rectum/sigmoid colon; tubular adenoacrinoma, moderately diff. 6. ¤Þ¤ì¤ÊÁÈ¿¥·Á¤ò¼¨¤·¤¿Æý´â¤Î1Îã¡¡ÀаæÏ¯»Ò¤Û¤«(ÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼) lipid-rich carcinoma with micropapillary pattern 7. ÇÙ¥¢¥ß¥í¥¤¥ÉÍÍ·ëÀá¤Î1Îã¡¡¹¾²Ïͦ¼ù¤Û¤«(ÀŲ¬»ÔΩÀجɱ¡) pulmonary hyalinizing granuloma; right chain deposition 8. ·ÛÉô¥ê¥ó¥ÑÀá¼ðáç¤Î1Îã¡¡ÂçÄͽٲð¤Û¤«(É;¾°å²ÊÂç³ØÉí°É±¡, ˶¶»Ô̱ɱ¡) interdigitating dendritic cell sarcoma ¾ÉÎ㸡Ƥ²ñ½ªÎ»¸å¡¡¡Ö¤Ò¤³¤Í¡×¤Çº©¿Æ²ñ Âè249²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †Âè249²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï¾ëÆî-ÀŲ¬ÉÂÍý¹çƱ¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ç¤¹¡£ Âè248²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2014ǯ10·î18Æü(ÅÚ)¡¡ÀŲ¬»ÔÃ˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢B1¡¡Â¿ÌÜŪ¼¼ 1. æú¹ü¼ðáç¤Î1Îã¡§81ºÐÃËÀ¡¡Ê¡ÅçËãͳ, ÇϾìÁï¡¡É;¾°åÂçÉհɱ¡ myeloid sarcoma with megakaryocytic differentiation (megakaryocytic sarcoma) 2. ¥¿¥â¥¥·¥Õ¥§¥óÎÅË¡Ãæ¤Î»ÒµÜÆâËì¥Ý¥ê¡¼¥×¾õÉÂÊѤÎ1Îã 20ºÐÂå½÷À¡¡Ìܹõ»Ë¿¥, ÎëÌÚÀ¿¡¢¿·°æ°ì¼é, ¼¼ÇîÇ·¡¡É;¾°å²ÊÂç³Ø, ÀŲ¬¸©Î©Áí¹çɱ¡ Borderline mixed epithelial and mesenchymal tumor or low-grade adenosarcoma 3. EBV´ØÏ¢¥ê¥ó¥ÑÁý¿£¾É¤Î°ìÎã 81ºÐÃËÀ¡¡¼¼ÇîÇ·¡¡ÀŲ¬¸©Î©Áí¹çɱ¡ age-related EBV associated LPD of the stomach 4. ÇÙ¤ÎNUT midline carcinoma¤Î°ìÎã¡¡36ºÐ½÷À¡¡ÎëÌÚĬ¿Í, ÂçÀ¾°ìÊ¿, ¿ú¼½Õɧ, 벬½ñɧ¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃÇ¡¢É;¾°å²ÊÂç³Ø¼ðáçÉÂÍý³Ø¹ÖºÂ 5. ¹â·ì°µ¤òȼ¤Ã¤¿¿Õ¼ðáç¾ÉÎã 15ºÐ¡¡½÷À¡¡ÉͺêË¡¡ÀŲ¬¸©Î©¤³¤É¤âɱ¡ jaxtaglomerular cell tumor of the kidney (JGCT) 6. ÆýÁ£¼ðáç¤Î°ìÎã¡¡30ºÐÂå¸åȾ½÷À¡¡Âç·î´²Ïº¡¡À»ÎìÉ;¾É±¡ periductal stromal sarcoma and invasive ductal carcinoma 7. ºÇ¶á·Ð¸³¤·¤¿ÇÙ¼ðáç¤Î°ìÎã 79ºÐ½÷À¡¡ÃæÅç¹§¡¡ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ mucinous AIS-like bronchiolar cell hyperplasia [ (Lambertosis) Peribronchiolar metaplasia] Âè247²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2014ǯ8·î31Æü¡¡ÀŲ¬»ÔΩÀجɱ¡¡¡À¾´Û12³¬¹ÖƲ £±. ¼ª²ðÈéÉæ¼ðáç¡§12ºÐ½÷À ÇϾ졡Áï¡ÊÉ;¾°åÂç¡ËAtypical cellular blue nevus £²¡¥Î×¾²Åª¤ËǾ°À¥ê¥ó¥Ñ¼ð¡¢Ç¾Ç¿áç¡¢¤Ê¤¤¤· CNS ¥ë¡¼¥×¥¹¤¬µ¿¤ï¤ì¡¢À¸¸¡¤Ç¹â°ÀÅÙ¥°¥ê¥ª¡¼¥Þ¤È¿ÇÃǤ·¤¿£±Îã £³¡¥Ù¨Ê¿¾åÈé´â¤Ø¤Îʬ²½¤¬ÃøÌÀ¤Ê»ÒµÜÆâËìÁ£´â¤ÈÍñÁã¤Î»ÒµÜÎàÆâËìǹ¼ð¤òȼ¤¦Ù¨Ê¿¾åÈé´â¤Î£²Îã £´¡¥À¸¸å£·Æü(F)¡§ Èé²¼¡¢¹ü¤Î¿ȯÉÂÊÑ¡¢·ëIJÉÂÊÑ ÉͺꡡˡÊÀŲ¬¸©Î©¤³¤É¤âɱ¡¡ËInfantile myofibromatosis, multicentric £µ¡¥Ä²´É¶¹ºõ¤¬¸«¤é¤ì£Ó¾õ·ëIJ´â¤¬µ¿¤ï¤ì¤¿£±Îã¡×¿¹¡¡¹°¼ù¡ÊÉ;¾°åÎÅ¥»¥ó¥¿¡¼¡ËAtypical endosalpingosis with endometriosis of the sigmoid colon £¶¡¥±¦ÂçÂÜÈéÉæ¼ðáç¡§29ºÐ½÷À¡×ÇϾ졡Áï¡¢¸åÆ£¿¿Æà¡ÊÉ;¾°åÂç¡ËMyoepithelioma, suspicious of, of the skin Ï¢Íí»ö¹à
Âè245²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2013ǯ8·î31Æü¡¡ÀŲ¬¾¦¹©²ñ¡¡¸á¸å1:30¡Á¡¡6Âê¤Î±éÂ꤬ȯɽ¤µ¤ì¤Þ¤·¤¿¡£ 1. ÃøÌÀ¤Ê¹¥»Àµå¿»½á¤òȼ¤Ã¤¿Èé²¼¼ðáî¤Î2Îã 2. p53°äÅÁ»Ò¤Îµ©¤ÊÊѰÛ, M133K¤òͤ¹¤ëľIJ¿À·ÐÆâʬÈç´â¤Î1Îã 3¡¥¥µ¥ë¥³¥¤¥É¡¼¥·¥¹¤Ë¹çÊ»¤·¤¿PML¤Î°ìÎã 4¡¥ÍñÁã¼ðáç 5. ç¯æù¼ðáç¤Î2Îã 6. ÈéÉæ¼ðáç¤Î2Îã Âè244²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2013ǯ6·î20Æü¡¡ÃæÅì±ó°åÎÅ¥»¥ó¥¿¡¼ ¿·É±¡¤Î¹ÖƲ¤Ç¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤¬¹Ô¤ï¤ì¤Þ¤·¤¿¡£ 1. ÀÚ½ü¤ÈºÆÈ¯¤ò·«¤êÊÖ¤·¤¿±¦²¼´ãâÛÈé²¼¼ðáî¤Î1Îã 2. º¸¸åðôÉôÈé²¼¼ðáî ÇϾì Áï É;¾°å²ÊÂç³ØÉí°É±¡ÉÂÍý¿ÇÃÇ²Ê Desmoplastic melanoma. 79ºÐ½÷À¡¡S-100 positive spindle cells. DM or MPNST? ´ÕÊ̺¤Æñ¡£ 3. ¼ê¤Ä¤Ê¤®´â »°±º ¹îÉÒ É;¾°å²ÊÂç³Ø´Ç¸î³ØÉô gastric cancer of "hand-shaking" type 50ºÐÂåÃËÀ¡¡°ß 4¡¥Behcet disease ¤ÎIJ´ÉÉÂÊÑ 5. myogenin ÍÛÀ¤ò¼¨¤·¤¿Á°½Ä³ÖȯÀ¸large cell neuroendocrine carcinoma(LCNEC)¤Î°ìÎã 6¡¥Æ¬³¸Äì¼ðáç¤Î°ìÎã 7¡¥º¸¿Õ¼ðáç¤Î°ìÎã À¶¿å¿Ê°ì¤Û¤«¡¡À»ÎìÉ;¾É±¡ÉÂÍý 60ºÐÂåÃËÀ´µ¼Ô¤µ¤ó¡£ ÆýƬ¾õ¿ÕºÙ˦´â PRCC(solid variant, low-grade spindle cell foci) or Ç´±Õ´É¾õË¿îºÙ˦´â MTSCC (mucin-poor variant) Âè243²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2013ǯ4·î20Æü¸á¸å1:30¡Á¡¡¡÷ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢4³¬²ñµÄ¼¼¡¡5Âê¤Î±éÂ꤬ȯɽ¤µ¤ì¤Þ¤·¤¿¡£ £±¡¥¡ÖOsler-Weber-RenduɤËÀ¸¤¸¤¿Â¿È¯À´Î·ëÀáÀÉÂÊÑ¡×: 1. focal nodular hyperplasia-like nodule 2. telangiectasis(Osler-Weber-Rendu disease) £²¡¥Á𿼠¸ø½¨¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ë ¡¡¡ÖÊ£»¨¤ÊÁÈ¿¥Áü¤òÄ褷¤¿°ß´â¤Î£±Îã¡× £³¡¥¡Öº¸´éÌÌËËÉôÍ·ÔÀ¼ðáç¤Î£±Îã¡×¡§compatible with so called (cutaneous) mixed tumor £µ¡¥¡ÖÂçIJ¿ȯ¥Ý¥ê¡¼¥×¤Î1Îã¡×: Mantle cell lymphoma manifesting as multiple lymphomatous polyposis SPS¤Î¤¢¤È¡¢16»þ¤«¤éÀŲ¬±ØÆî¤Î¡Ö¥Û¥Æ¥ë¥»¥ó¥Á¥å¥ê¡¼ÀŲ¬¡×¤Ç¡Ö°äÅÁ»Ò¸¡ºº¤Î¥»¥ß¥Ê¡¼¡×¡Ê»Ê²ñ¡§¿ú¼ÀèÀ¸¡Ë Âè242²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †Âè242²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï¾ëÆîÉÂÍý-ÀŲ¬ÉÂÍýSPS¹çƱ¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤È¤·¤Æ, 2012ǯ10·î13Æü(ÅÚÍËÆü),¡¡NTTÅìÆüËÜ´ØÅìɱ¡¤Ë¤Æ³«ºÅ¤µ¤ì8Âê¤Î¾ÉÎãÊó¹ð¤ÈÆÃÊֱ̹餬¤ª¤³¤Ê¤ï¤ì¤Þ¤·¤¿¡£---> SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø°Üư Âè241²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2012ǯ7·î28Æü¸á¸å1:30¡Á¡¡¡÷ÀŲ¬¸©Ã˽÷¶¦Æ±»²²è¥»¥ó¥¿¡¼¤¢¤¶¤ì¤¢4³¬²ñµÄ¼¼¡¡7Âê¤Î±éÂ꤬ȯɽ¤µ¤ì¤Þ¤·¤¿¡£ £±¡¥¡ÖÂçÆ°Ì®ÊÛ¶¹ºõ¾É¡× £²¡¥¡ÖPrimary splenic diffuse large B cell lymphoma manifesting in red pulp¤È¹Í¤¨¤é¤ì¤ë°ìÎã¡× £³¡¥¡Ö¿¿À·Æ¼¼Í³Íè¤È¹Í¤¨¤é¤ì¤¿¾å¹Ô·ëIJµðÂçÇ´±Õ´â¤Î°ìÎã¡× £´¡¥¡ÖÌ®´É¿¯½±¤Î¸«Êý¡¦¹Í¤¨Êý¡½´Î¤¬¤ó¡¢¿Õ¤¬¤ó¡¢¹Ã¾õÁ£¤¬¤ó¤Î·ì´ÉÆâ¿¯ÆþÍͼ°¡½¡× £µ¡¥¡Ö¸ý¹ÐÆðÉô¼ðáç¤Î£±Îã¡× £¶¡¥¡Öº¸³Ü²¼Á£¼ðáç¤Î°ìÎã¡× £·¡¥¡ÖEncapsulated liver cell tumor¤Î£±Îã¡× Âè240²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2012ǯ5·î25Æü¸á¸å1:30¡Á¡¡¡÷É;¾»ÔÃϰè¾ðÊ󥻥󥿡¼£³³¬¡¡£µÂê¤Î±éÂ꤬ȯɽ¤µ¤ì¤Þ¤·¤¿¡£ 1.¡ÖIgG4¾å¾º¤òȼ¤Ã¤¿ÈéÉæ¤ÈÇ٤Υê¥ó¥ÑÁý¿£ÀÉÂÊѤΣ±Îã¡× 2.¡ÖÇÙ¼ðáç¤Î£²Îã¡× 3.¡Ö¿ÇÃÇ¤ËÆñ½Â¤·¤¿¶»Ëì¼ðáç¤Î£±Îã¡× 4.¡ÖA case of neuroendocrine carcinoma of the male breast¡× 5.¡Ö¥¿¥â¥¥·¥Õ¥§¥óÅêÍ¿Æý´â´µ¼Ô¤Ëȯ¾É¤·¤¿ steatohepatitis¡× Âè239²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †Âè239²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤ª¤è¤ÓÂè1²óÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ÀìÌçÉÂÍý°åÍÜÀ®¸¦½¤²ñ¡¡2011ǯ12·î3Æü¡ÊÅÚÍËÆü¡Ë¸á¸å1:00¡Á17:00 ÀŲ¬»Ô¥Û¥Æ¥ë¥×¥ê¥ô¥§ÀŲ¬¥¹¥Æ¡¼¥·¥ç¥ó¡¡¾ÉÎã±éÂê2Îã¤È¹Ö±é2Âê £±¡¥¡ÖÇÙ¼ðáç¤Î1Îã¡×É;¾°åÂçÉí°É±¡ Ê¡ÅèËãͳ-- Mixed squamous cell and glandular papilloma¡¡¾ÉÎã¤Î¥Ú¡¼¥¸¤ò¸«¤ë £²¡¥¡ÖÂçIJÆâʬÈçºÙ˦´â¤Î£±Îã¡×À»ÎìÉ;¾É±¡ ¹¾²Ïͦ¼ù-- Mixed adenoneuroendocrine carcinoma, large cell type with squamous cell differentiation¡¡¾ÉÎã¤Î¥Ú¡¼¥¸¤ò¸«¤ë Âè1²óÀìÌçÉÂÍý°åÍÜÀ®¸¦½¤²ñ¹Ö±é¡¡ ÂçIJ¾åÈéÀ¼ðáç¤ÎÉÂÍý¿ÇÃÇ¡¡½çŷƲÂç³ØÂç³Ø±¡°å³Ø¸¦µæ²Ê¡¡È¬ÈøÎ´»Ë ÇÙ´â¤ò¤á¤°¤ë¥Û¥Ã¥È¥È¥Ô¥Ã¥¯:(1)ÇÙÁ£´âWHOʬÎà²þÄû¤ò¤á¤°¤Ã¤Æ (2)¿À·ÐÆâʬÈç¼ðáç¤ÎÀ¼Á¤È¿ÇÃÇ¡¡¤¬¤ó¸¦µæ½ê¡¡ÀÐÀîͺ°ì Âè238²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †Âè238²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï¾ëÆîÉÂÍý-ÀŲ¬ÉÂÍýSPS¹çƱ¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤È¤·¤Æ, 2011ǯ9·î17Æü(ÅÚÍËÆü),¡¡»°Åç»Ô̱²ñ´Û¤Ë¤Æ³«ºÅͽÄꤵ¤ì6Âê¤Î¾ÉÎãÊó¹ð¤ÈÆÃÊֱ̹餬¤ª¤³¤Ê¤ï¤ì¤Þ¤·¤¿¡£---> SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø°Üư Âè237²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2011ǯ8·î6Æü(ÅÚ) 13:30-17:00 £±¡¥¡ÖCD30-positive thymic well differentiated neuroendocrine carcinoma (carcinoid) ¤Î£±Îã¡× --->¾ÉÎã¤Î¥Ú¡¼¥¸ £²¡¥¡ÖLow grade¤Î¹ü¤Îsarcoma¡× £³¡¥¡ÖSexcord-stromal tumor (adult granulosa cell tumor, theca cell- fibroblastic tumor, and Sertoli-stromal cell tumor) ¤Î£³¾ÉÎã¡× £´¡¥¡ÖÂÛÈ×29wÀÚÇ÷ÁỺ¡¢¾ï°ÌÂÛÈ×Áá´üÇíÎ¥¡× £µ¡¥¡ÖEBV´¶À÷¤òȼ¤¦Àü¹¦À¶õIJÄÙáç¡¢polymorphic lymphoproliferative disorder¡¢82ºÐÃËÀ¡× £¶¡¥¡Ö¿ÇÃÇ¤ËÆñ½Â¤·¤¿¥ê¥ó¥ÑÀáÉÂÊѤΣ±Îã¡×
Âè236²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2011ǯ5·î28Æü(ÅÚ) 13:30-17:00 1.¡Ö²¼³Ü¼ðáç¤Î°ìÎã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸ 2.¡ÖÀ®½Ïǹ˦´ñ·Á¼ð¤ËÈéÉæÉÕ°´ï¼ðáç¤ò¹çÊ»¤·¤¿°ìÎã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸? 3.¡ÖÌçÌ®Êĺɤª¤è¤Ó´ÎÆâÃÀ´É¶¹ºõ, ³ÈÄ¥¤ò¤·¤á¤·¤¿¾åÉôÃÀ´É´â¤Î°ì˶¸¡Îã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸ 4.¡ÖǾÆâ¿ȯÀÇò¼ÁÉÂÊѤΰìÎã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸? 5.¡Ö±¦Â¦Ç¾¼¼¼ðáç¤Î°ìÎã¡×--->subependymoma of the rt. lateral ventricle ¾ÉÎã¤Î¥Ú¡¼¥¸ 6.¡Ö磼ð¤ÈµÞÀ´Î±ê¤È¿ÇÃǤµ¤ì¤¿°ìÎã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸ 7.¡ÖÊ¢¿åºÙ˦¿Ç¤Çȯ¸«¤µ¤ì¤¿¥Ð¡¼¥¥Ã¥È¥ê¥ó¥Ñ¼ð¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸?
Âè235²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2011ǯ3·î26Æü(Æü)¡¡13:30-17:00 1.¡ÖSpindle cell lipoma ¤Î£±Îã¡×¹¾²Ï ͦ¼ù¡ÊÀ»ÎìÉ;¾É±¡¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸? 2.¡ÖMicropapillary component ¤¬Í¥Àª¤Ç¤¢¤Ã¤¿ÂçIJ´â¤Î°ì¼ê½ÑÎã¡×Á𿼠¸ø½¨¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸? 3.¡Ö¿À·Ð¾É¾õ¤ò½éȯ¤È¤·¤¿¸Â¶É·¿WegenerÆù²ê¼ð¾É¤Î£±Ë¶¸¡Îã¡×³Þ¸¶ ÀµÃË,¡¡ÅÄÂå Ϲ°¡ÊÀŲ¬ÀÖ½½»úɱ¡¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸? ¡Ú¹Ö±é¡Û¡¡¡¡
¡Ö°ß´â¼£ÎÅÊý¿Ë¤Ë´Ø¤ï¤ëÉÂÍý¿ÇÃÇ¡ÝToGA»î¸³¤è¤ê¡Ý¡× 4.¡Ö°ß°À¥ê¥ó¥Ñ¼ð¤Îµ¿¤¤¤Î£±Îã¡×ÌÚ²¼ ¿¿Æà¡ÊÉ;¾°åÂçÉí°É±¡ÉÂÍýÉô) --->lymphomatoid gastropathy ¾ÉÎã¤Î¥Ú¡¼¥¸ 5.¡ÖǾ¤Î inflammatory pseudotumor ¤Î£±Îã¡×
Âè234²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2011ǯ1·î22Æü(ÅÚ) 13:30-17:00 £±¡¥¡Ö£µÇ¯´Ö¤Îç¯æù´â¼£ÎÅÃæ¤ËȯÀ¸¤·¤¿±¢·ÔÉôǢƻ¼ðáç¤Î£±Îã¡×--->¾ÉÎã¤Î¥Ú¡¼¥¸ £²¡¥¡ÖÆñ¼£ÀÄÙáç¤òȼ¤¦°ß¼ðáçÀÉÂÊÑ¡× £³¡¥¡Ö¿©Æ»¼ðáç¤Î£±¼ê½ÑÎã¡× £´¡¥¡ÖPTXÅêÍ¿´µ¼Ô¤Ëȯ¾Í¤·¤¿ARDS¡× £µ¡¥¡ÖÆâʬÈçºÙ˦ͥ°ÌDCIS¡× £¶¡¥¡ÖÇÙbasaloid squamous cell carcinoma¤Î£±Ë¶¸¡Îã¡× £·¡¥¡ÖºÇ¶á·Ð¸³¤·¤¿ALKÇٴ⣴Îã¤ÎÁÈ¿¥³ØÅªÆÃħ¡×
Âè233²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †2010ǯ11·î20Æü(ÅÚ) 13:30-17:00 1. ¡ÖµÞÀ¹ü¿ñÀÇò·ìɼ£ÎŤ˽и½¤·¤¿±¦·ÛÉô¼ðáî¤Î1Îã¡×¡¡Áð´Öͳµª»Ò(É;¾°å²ÊÂç³ØÉí°É±¡)--->¾ÉÎã¤Î¥Ú¡¼¥¸¤Ø 2. ¡Ö²õ»àÀ¶ÚËì±ê¤Î1Îã¡×¡¡ÌÚ²¼¿¿Æà(É;¾°å²ÊÂç³ØÉí°É±¡)--->¾ÉÎã¤Î¥Ú¡¼¥¸? 3. ¡Ö12ºÐ½÷»ù¤ÎÆýÁ£¼ðáî¡×¡¡ÉͺêË, ´äÊ¥±Ñ¿Í, ¹â·¬·ÃÈþ(¸©Î©¤³¤É¤âɱ¡)--->¾ÉÎã¤Î¥Ú¡¼¥¸ 4. ¡Ö²óÌÕÉô¼ðáî¤Ç, ¶ÛµÞ¼ê½Ñ¤È¤Ê¤Ã¤¿50ºÐÂåÃËÀ¡×Á°Â¿¾¾´î(˶¶»Ô̱ɱ¡)--->¾ÉÎã¤Î¥Ú¡¼¥¸ 5. ¡ÖÉû¿ÕÈé¼ÁÁ£¼ð(Cushing¾É¸õ·²),¹Ã¾õÁ£ÆýƬ´â, ç£Â¡¼ðá礪¤è¤ÓÊ¢¹ÐÆâ¿ȯ¼ðáç¤Î1Îã¡×ÇϾìÁï¡ÊÉ;¾°å²ÊÂç³ØÉí°É±¡) 6. ¡ÖDisseminated calcifying tumor of the pleura¤Î1Îã¡×¡¡ÃæÅç¹§(ÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼)--->¾ÉÎã¤Î¥Ú¡¼¥¸¤Ø? 7. ¡ÖÇ¥¿±Ãæ¤ÎµÞÀÃî¿â±ê¤Î1Îã¡×¿¹¹°¼ù(¸©À¾ÉôÉ;¾°åÎÅ¥»¥ó¥¿¡¼)---> ¾ÉÎã¤Î¥Ú¡¼¥¸¤Ø? Âè232²óÀŲ¬ÉÂÍý°å²ñ(SPS)¥«¥ó¥Õ¥¡¥ì¥ó¥¹ †Âè232²óSPS¥«¥ó¥Õ¥¡¥ì¥ó¥¹¤Ï¾ëÆîÉÂÍý-ÀŲ¬ÉÂÍý°å²ñ¹çƱÉÂÍý½¸Ã̲ñ Johnan SPS Joint Pathology Conference¤È¤Ê¤ê¤Þ¤¹¡£ Âè231²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2010ǯ8·î21Æü(ÅÚ) 13:30-17:00 £±¡¥¡Öplacental mesenchymal dyplasia ¤Î£²Îã¡×¹¾²Ïͦ¼ù¡¢Âç·î´²Ïº¡¢À¶¿å¿Ê°ì¡ÊÀ»ÎìÉ;¾É±¡) --->¾ÉÎã¤Î¥Ú¡¼¥¸ £²¡¥¡ÖMethotrexate ´ØÏ¢¥ê¥ó¥ÑÁý¿£¼À´µ¤Î£±Îã¡×¿¹ÌÚÍø¾¼¡ÊÀŲ¬»ÔΩÀجɱ¡¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸ £³¡¥¡Ö³Ü²¼¥ê¥ó¥ÑÀá¼ðáî¤Î£±Îã¡×ÌÚ²¼¡¡¿¿Æà£±, À±¡¡¾¼Æó2¡Ê1É;¾°åÂçÉÂÍýÉô, 2ÀŲ¬ºÑÀ¸²ñÁí¹çɱ¡¡Ë-->¾ÉÎã¤Î¥Ú¡¼¥¸ £´¡¥¡Ö±¦ÚÕ°öƬ´Ö·ä¼ðáç¤Î£±¼ê½ÑÎã¡×Á𿼠¸ø½¨¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ë £µ¡¥¡Ö¿ȯÇÙÆâž°Ü¤ò¹Í¤¨¤¿°Û·¿II·¿¾åÈé²á·ÁÀ®¤òȼ¤¦ÇÙ±ê¤Î£±Îã¡×ÃæÅç¡¡¹§¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡Ë £¶¡¥¡ÖÂçÂܹü¤ª¤è¤Ó¹üÈ×¹ÐȯÀ¸ giant cell tumor with malignant potential ¡Êmalignant fibrous histiocytoma, giant cell type¡Ë ¤Î£²¾ÉÎã¡× £·¡¥¡Ö²èÁü¤Ç°À¤È¤Î´ÕÊ̤Τऺ¤«¤·¤¤ÅüÇ¢ÉÂÀ¥Þ¥¹¥È¥Ñ¥Á¡¼¤Î£±Îã¡×»°±º¹îÉÒ¡ÊÉ;¾°åÂç·ò¹¯²Ê³Ø¡Ë £¸¡¥¡ÖÇÙ¼ðáç¤Î£±Ë¶¸¡Îã pulmonary blastoma ¤È¤¹¤Ù¤¤« carcinosarcoma ¤È¤¹¤Ù¤¤«¡©¡×¿¹¡¡¹°¼ù¡Ê¸©À¾ÉôÉ;¾°åÎÅ¥»¥ó¥¿?¡Ë ½ªÎ»¸å¡¢¡Ö½½Àé²ÖÁ°¡×¤Ë¤ÆÇ¼Îòñ ±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò[[¥À¥¦¥ó¥í¡¼¥É:]
Âè230²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2010ǯ6·î26Æü(ÅÚ) 13:30- 17:00 1.¡ÖPapillary fibroelastoma ¤Î£²Îã¡× ¡¡ÂçÀÐ °ìÊ¿£±¡¢¿·Â¼ ÏÂÌ飲¡¢±óÆ£ ͺ»°£²¡¢¿ú¼ ½Õɧ£² ¡Ê1.É;¾°åÂç°å³Ø²Ê£¶Ç¯¡¢2.É;¾°åÂçÂè°ìÉÂÍý³Ø¹ÖºÂ¡Ë 2.¡ÖÈéÉæ¼ðáç¡× ¡¡À¶¿å ¿Ê°ì, ¹¾²Ïͦ¼ù, Âç·î´²Ïº ¡ÊÀ»ÎìÉ;¾É±¡ÉÂÍý²Ê¡Ë 3.¡Ö¥·¥ã¥ó¥È¼À´µ¤¬µ¿¤ï¤ì¤¿¹â¿´Çï½ÐÀ¿´ÉÔÁ´¤Î£±Ë¶¸¡Îã¡× ¡¡¿¹ÌÚ Íø¾¼ ¡ÊÀŲ¬»ÔΩÀجɱ¡ÉÂÍý²Ê¡Ë 4.¡ÖÍñÁ㡦ʢËì¤ÎɽºßÀÞùËìÀÆýƬ´â(SSPC)¤Î£³Îã¡× ¡¡³Þ¸¶ ÀµÃË¡¢ÅÄÂå Ϲ° ¡ÊÀŲ¬ÀÖ½½»úɱ¡ÉÂÍýÉô¡Ë 5.¡Ö¸å½Ä³Ö¼ðáç¤Î£±Îã¡× ¡¡´äÊ¥ ±Ñ¿Í ¡ÊÀŲ¬¸©Î©¤³¤É¤âɱ¡Î×¾²ÉÂÍý²Ê¡Ë 6.¡Ö°ß¤ÎÄãʬ²½·¿Á£´â¤Ë°ß¸¶È¯ßÉ˦À¥ê¥ó¥Ñ¼ð¤ò¹çÊ»¤·¤¿£±Îã¡× ¡¡ÃæÂ¼ ±Ù»Ò ¡Ê˶¶°åÎÅ¥»¥ó¥¿¡¼Î×¾²¸¡ºº²Ê¡Ë--->¾ÉÎã¤Î¥Ú¡¼¥¸? 7.¡ÖÆÃ°Û¤ÊÉô°Ì¤Ëȯ¾É¤·¤¿ extranodal NK/T-cell lymphoma, nasal type ¤Î£±Îã¡× ¡¡¼¼¡¡ÇîÇ·1¡¢ÎëÌÚ¡¡À¿1¡¢¿·°æ °ì¼é1¡¢ÇϾ졡Áï2¡¢²ÃÆ£ ÃÒ¹Ô2 ¡Ê1.ÀŲ¬¸©Î©Áí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¢2.É;¾°åÂçÉÂÍýÉô¡Ë 8.¡Öperforin¤¬ÍÛÀ¤ò¼¨¤¹Âç·¿°Û·¿ºÙ˦¤Î½Ð¸½¤·¤¿°À¥ê¥ó¥Ñ¼ð¤Î°ìÎã¡× ÂçÀС¡Ä¾µ±1¡¤Ã«²¬ ½ñɧ1, ¿ú¼¡¡½Õɧ2(1.ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¿ÇÃDzʡ¢2.É;¾°åÂçÂè°ìÉÂÍý³Ø¹ÖºÂ) ±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò¥À¥¦¥ó¥í¡¼¥É Âè229²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2010ǯ4·î17Æü(ÅÚ)¡¡13:30- 17:00 1.¡¡¡ÖÆù¼ðÀ®Ê¬¤Ë̤ʬ²½¿À·ÐÁÈ¿¥¤òǧ¤á¤ëðôÉôȯÀ¸¤È¹Í¤¨¤é¤ì¤¿»ÒµÜ´âÆù¼ð¤Î°ìÎã¡× 2. ¡ÖÀ¸¸åÁá´ü¤è¤êÆ©ÀϤòɬÍפȤ·¤¿1˶¸¡Îã¡× 3. ¡Ö98ºÐ½÷À¡¢108ºÐ½÷À¡¡Ï·¿ÍÀ¥¢¥ß¥í¥¤¥É¡¼¥·¥¹¤Î2Îã¡× 4. ¡Ö·Ðµ¤Æ»À¿ÊŸ¤ò¼¨¤¹Äãʬ²½ÇÙÁ£´â¤Î°ìÎã¡× 5. ¡ÖÃæÉô¿©Æ»Îΰè¤ËȯÀ¸¤·¤¿basalioid carcinoma with adenoid cystic carcinoma
fearture ¤Î°ìÎã¡× 6. ¡Ö±¦¼ª²¼Á£°À¼ðáç¤Î°ì¼ê½ÑÎã¡× 7. ¡ÖľIJ´âÊ¢ËìÇżï¤Îµ¿¤¤¡× ±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò¥À¥¦¥ó¥í¡¼¥É Âè228²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2010ǯ2·î27Æü(ÅÚ) 13:30- 17:00 1. ¡ÖUterine tumors resembling ovarian sex cord tumor (UTROSCT) ¤Î°ìÎã¡× 2. ¡Ö°ß³êËìÆù¼ð¤Î£±¾ÉÎã¡× 3. ¡Ö»ÒµÜ·ÛÉô¥¹¥ê¥¬¥é¥¹ºÙ˦´â¤Î1Îã¡×»°±º¹îÉÒ¡ÊÉ;¾°å²ÊÂç³Ø ·ò¹¯²Ê³Ø)--->¾ÉÎã¤Î¥Ú¡¼¥¸ 4. ¡Ö¶»Êɼðáç¤Î£±Îã¡×¿¹ÌÚ Íø¾¼ (ÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý²Ê)--->¾ÉÎã¤Î¥Ú¡¼¥¸? 5.¡ÖCD3, CD20, bcl-2 ÌȱÖÀ÷¿§¤ÎÎ×¾²¸¡ººÀºÅÙ´ÉÍýÄ´ººÊó¹ð¡×·ªÅÄ¡¡¾¼¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ Î×¾²¸¡ºº²Ê)--->ÀºÅÙ´ÉÍý¤Î¥Ú¡¼¥¸? 6.¡Ö·ìÀ¶IgG4¹âÃͤò¼¨¤·¤¿¸¶È¯À¹Å²½ÀÃÀ´É±ê¤Î°ìÎã¡× 7.¡ÖÂçIJ¤ÎÆâʬÈçºÙ˦´â¤Î°ìÎã¡× 8. ¡Ö¿§ÁÇÄÀÃå¤òȼ¤Ã¤¿¸ý¹ÐÆâ¼ðáç¤Î°ìÎã¡× 9. ¡ÖALKÍÛÀÇÙ´â¤Î4Îã¡× ±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò¥À¥¦¥ó¥í¡¼¥É Âè227²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2009ǯ12·î5Æü¡ÊÅÚ¡Ë14:00¡½17:00 ºÂĹ¡§°ËÆ£ °ÊÃÎϺ¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃÇ²Ê¡Ë 1. ¡Ö±ê¾ÉÀ¼ðáî¤È´ÕÊ̺¤Æñ¤Êž°ÜÀÇÙ¼ðáî¤ò·ÁÀ®¤·¤¿°ß T-cell lymphoma ¤È¹Í¤¨¤é¤ì¤ë¾ÉÎã¡× 벬 ½ñɧ¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ Î×¾²¸¡ºº²Ê¡Ë--> ¾ÉÎã¤Î¥Ú¡¼¥¸? 2. ¡Ö·ì´É¼þ°ÏÀµ¶¥í¥¼¥Ã¥È¤òȼ¤¦Ç¾¼ðáç¤ÈµðÂç¶»¹ÐÆâ¼ðáç¤Î°ìÎã¡× À¾¸¶ ¹°¼£¡Ê»ÔΩÅçÅÄ»Ô̱ɱ¡ ÉÂÍý¿ÇÃÇ²Ê¡Ë 3. ¡Ö¿ÇÃÇ¤Î¶Ë¤á¤ÆÆñ¤·¤«¤Ã¤¿¾®»ù¤ÎËËÉôÆðÉô¼ðáç¤Î1Îã¡× »°±º ¹îÉÒ¡ÊÉ;¾°å²ÊÂç³Ø ´ðÁôǸî·ò¹¯²Ê³Ø¡Ë 4. ¡ÖParacoccidioidomycosis¡×¤Î1Îã¡× ÃæÅç ¹§¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃÇ²Ê¡Ë ºÂĹ¡§ÃæÅç ¹§¡ÊÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃÇ²Ê¡Ë 5. ¡ÖËܱ¡¤Ç·Ð¸³¤·¤¨¤¿Èæ³ÓŪµ©¤ÊÆý´â¤Î2¾ÉÎã¡× ³Þ¸¶ ÀµÃË¡ÊÀŲ¬ÀÖ½½»úɱ¡ ÉÂÍýÉô¡Ë 6. ¡ÖPseudomyxoma peritonei ¤Î1Îã¡× ÎëÌÚ À¿¡ÊÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃÇ²Ê¡Ë 7. ¡ÖǾ¼¼´â¤Î1Îã¡× ¼¼ ÇîÇ· (ÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¿ÇÃDzÊ) 8.¡Ö·ÛÉô¥ê¥ó¥ÑÀá¼ðáç¤Î1Îã¡× ¾®¿ù °Ë»°ÉסÊÉ;¾°å²ÊÂç³Ø ÉÂÍý³ØÂèÆó¹ÖºÂ)--->CD4+,CD56+ Hematodermal tumor, ¼À´µ²òÀâ¤È¾ÉÎã Âè226²óÀŲ¬ÉÂÍý°å²ñ(SPS) †Âè226²ó¤ÏSPS¡¦¾ëÆîÉÂÍý½¸Ã̲ñ¤È¤Ê¤ê¤Þ¤¹¡£¡¡2009ǯ9·î27Æü(ÅÚ) -->»°Åç»ÔÅì¥ì¸¦½¤¥»¥ó¥¿--> SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø Âè225²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2009ǯ7·î4Æü¡¡ÀŲ¬»Ô¤¢¤¶¤ì¤¢Ã˽÷»²²è¶¦Æ±¥»¥ó¥¿¡¼Â¿ÌÜŪ¼¼ ¡¡²ñ½ªÎ»¸åǼÎòñ¡÷¶äºÂ¥é¥¤¥ª¥ó 1. ¡Ö¸åÊ¢ËìImmature teratoma¤ò½éȯ¾É¾õ¤È¤·¤¿ÀºÁãmixed germ cell tumor¤Î£±Îã¡×ÂçÀРľµ±¡ÊÈØÅÄ»ÔΩÁí¹çɱ¡ Î×¾²¸¡ºº²ÊÉÂÍý¡Ë--->¼À´µ²òÀâ¤È¾ÉÎã 2. ¡Ö£·ºÐÃË»ù¡¡Â裴Ǿ¼¼¼ðáç ¡×»°±º ¹îÉÒ¡ÊÉ;¾°å²ÊÂç³Ø ´ðÁôǸî·ò¹¯²Ê³Ø¡Ë-->[[¼À´µ²òÀâ¤È¾ÉÎã>SPS225-Case02; 3. ¡Ö¹ü¿ñ°Ü¿¢¸åÁá´ü¤ËÃ×»àŪ¤ÊÇÙÉÂÊѤòÍ褷¤¿£±Îã¡×¹â¾ì ·ÃÈþ¡ÊÀŲ¬¸©Î©¤³¤É¤âɱ¡ Î×¾²ÉÂÍý²Ê¡Ë-->[[¼À´µ²òÀâ¤È¾ÉÎã>SPS225-Case03 4. ¡Ö±¦·ÛÉô¼ðáî¤Î£±Îã¡×¿¹ÌÚ Íø¾¼ (ÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý²Ê)-->[[¼À´µ²òÀâ¤È¾ÉÎã>SPS225-Case04; 5. ¡ÖÀÅÌ®¹Å²½¾É¤Ë¤è¤ëµõ·ìÀIJ±ê¤Î£±Îã¡×³Þ¸¶¡¡ÀµÃË¡ÊÀŲ¬ÀÖ½½»úɱ¡ ÉÂÍýÉô¡Ë--¼À´µ²òÀâ¤È¾ÉÎã 6. ¡Ö±¦ÇÙ¼ðáî (ÂèÆóÊó)¡×ÎëÌÚ¡¡À¿¡ÊÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¸¡ºº²Ê¡Ë--->[[¼À´µ²òÀâ¤È¾ÉÎã>SPS225-Case06 7. ¡Ö±¦É¨¾åÉôÈé²¼¼ðáî¤Î£±Îã¡×Ìܹõ »Ë¿¥ (É;¾°å²ÊÂç³Ø ÉÂÍýÉô)--->¼À´µ²òÀâ¤È¾ÉÎã Âè224²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2009ǯ4·î11Æü¡¡É;¾»ÔÃϰè¾ðÊ󥻥ó¥¿-²ñµÄ¼¼ 1. ¡Ö±¦ÇÙ¼ðáî¡×ÎëÌÚ¡¡À¿¡ÊÀŲ¬¸©Î©Áí¹çɱ¡ ÉÂÍý¸¡ºº²Ê¡Ë--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«? 2. ¡Ö¥ê¥ó¥ÑÀáÀü»ÉµÛ°úºÙ˦¿Ç¤Ë¤Æ Äãʬ²½´âž°Ü¤È¤Î´ÕÊÌ¿ÇÃÇ¤ËÆñ½Â¤·¤¿£±Îã¡×µÌ¡¡½¼¹°¡Ê»ÔΩÅçÅÄ»Ô̱ɱ¡ Î×¾²ÉÂÍý²Ê¡Ë--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«? 3. ¡Ö¸åȯÇÙž°Ü¤òÍ褷¤¿±¦¾å³Ü¼ðáç¤Î°ìÎã¡×Á𿼠¸ø½¨¡¢ÅÏî´ Îï»Ò¡¢°ËÆ£°ÊÃÎϺ¡¢ÃæÅç¡¡¹§¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«? 4. ¡Öº¸¾åÏÓ¹ü¼ðáç¡×¿¹ÌÚ Íø¾¼ (ÀŲ¬»ÔΩÀجɱ¡ ÉÂÍý²Ê)--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«? 5. ¡ÖÆýÁ£¥ê¥ó¥ÑÁý¿£À¼À´µ¤Î°ìÎã¡×¾¾±Æ ¾¼°ì¡¢ºç¸¶ °½»Ò¡¢Á°Â¿ ¾¾´î¡Ê˶¶»Ô̱ɱ¡ Î×¾²ÉÂÍý²Ê¡Ë--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«? 6.¡ÖºÇ¶á¤ÎÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¤Ë¤ª¤±¤ë¡¤PNET¤ª¤è¤Ó¤½¤ÎÎà±ï¼À´µ¤Î¿ÇÃǤˤĤ¤¤Æ¡×ÅÏî´ Îï»Ò¡ÊÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼ ÉÂÍý¿ÇÃDzʡË--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«? 7.¡ÖǾ¼ðáç¤Î1Îã¡×²Ïºê ½¨ÍÛ (É;¾°å²ÊÂç³Ø ÉÂÍý³ØÂèÆó¹ÖºÂ)--->Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«? 8.¡ÖÆðÉô¼ðá磲Îã ¤½¤Î¸å¡×¿¹¡¡¹°¼ù¡ÊÉ;¾°å²ÊÂç³Ø ÉÂÍý³ØÂè°ì¹ÖºÂ¡Ë---Î×¾²»ö¹à¡¦ÉÂÍý½ê¸«? ±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò¥À¥¦¥ó¥í¡¼¥É Âè223²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2009ǯ1·î31Æü¡¡ÀŲ¬»ÔΩɱ¡¡¡²ñ½ªÎ»¸åŽ¢¤Ò¤³¤ÍŽ£¤Ç¿·Ç¯²ñ 1.¡ÖÁ´¿È¥ê¥ó¥ÑÀá¼ðÂç¤ò¤¤¿¤·¤¿°ì¾ÉÎã¡×˶¶»Ô̱ɱ¡Î×¾²ÉÂÍý²Ê¡¡¾¾±Æ¾¼°ì, ºç¸¶°½»Ò, Á°Â¿¾¾´î--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 2.¡Öº¸³Û²¼Éô¼ðáç¤Î°ìÎã¡×ÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿¡¼ÉÂÍý¿ÇÃDzʡ¡Á𿼸ø½¨--->Î×¾²»ö¹à¡¦ÉÂÍýÁÈ¿¥½ê¸« 3.¡ÖÌȱÖÉÔÁ´¾õÂ֤ˤª¤±¤ëǾǿáç¤ÈÈ鲼ǿáç¤Î2Îã¡×É;¾°åÂçɱ¡ÉÂÍýÉô¡¡Ìܹõ»Ë¿¥--->Î×¾²»ö¹à¡¦ÉÂÍýÁÈ¿¥½ê¸« 4.¡ÖÇ٤˻¶ÉÛÀž°Ü¤ò¤¤¿¤·¤¿»ÒµÜ¶Ú¼ð¤Î1Îã¡×ÀŲ¬¸©Î©Áí¹çɱ¡¡¡¼¼ÇîÇ·, ¿·°æ°ì¼é, ÎëÌÚÀ¿---> 5.¡Ö¿ÇÃÇ¤ËÆñ½Â¤·¤¿ðùγµåÆù¼ð¤Î1Îã¡×ÀŲ¬ÀÖ½½»úɱ¡ÉÂÍýÉô¡¡³Þ¸¶ÀµÃË--->Î×¾²»ö¹à¡¦ÉÂÍýÁÈ¿¥½ê¸« 6.¡Ö³Ü´ØÀáÆð¹ü¼ð¤Îµ¿¤¤¡×É;¾°åÂç·ò¹¯²Ê³Ø¡¡»°±º¹îÉÒ---> 7.¡ÖµðÂç¸åÊ¢Ëì¼ðáî¤Î°ìÎã¡×¤ª¤è¤Ó¡ÖÂçÂÜÆðÉô¼ðáç¤Î°ìÎã¡×É;¾°åÂçÂè°ìÉÂÍý ¿¹¹°¼ù--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« ±éÂê¾ÉÎã¤ÎÎ×¾²»ö¹à¥×¥ê¥ó¥È´õ˾¤ÎSPS²ñ°÷¤ÎÊý¤Ï---> ¾ÉÎãÎ×¾²»ö¹à¤ò¥À¥¦¥ó¥í¡¼¥É Âè222²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2008ǯ11·î29Æü¡¡É;¾»ÔÁí¹çÄ£¼Ë 1.Ž¢Æý»ù¤Ëȯ¾É¤·¤¿¼ãǯ·¿ðùγËìºÙ˦¼ðŽ£¡¡ÀŲ¬¸©Î©¤³¤É¤âɱ¡¡¡ÉÂÍý¡¡¹â¾ì·ÃÈþ, ÉͺêË--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 2.Ž¢±¦¼ª²¼Á£¼ðáç¤Î°ìÎ㎣¡¡ÀŲ¬¸©Î©¤¬¤ó¥»¥ó¥¿- ÉÂÍý¿ÇÃDzʡ¡Á𿼸ø½¨--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 3.Ž¢Clostridium sordelli¤Ë¤è¤ëµÞÀÊ¢Ëì±ê¤Î1˶¸¡Î㎣ ¿º¸¶Áí¹çɱ¡¡¡ÉÂÍý¿ÇÃDzʡ¡À¾¸¶¹°¼£--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«? 4.Ž¢ÇÙ¥ê¥ó¥ÑÌ®´É¶Ú¼ð¾É¤Î1Î㎣¡¡À»ÎìÉ;¾É±¡¡¡ÉÂÍý¿ÇÃDzʡ¡¹¾²Ïͦ¼ù--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 5.Ž¢sCD3±¢À Blastic NK/T neoplasm¤Î1Î㎣¡¡ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡¡ÉÂÍý¿ÇÃDzʡ¡ÅÏî´Îï»Ò--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 6.Ž¢Primary cutaneous follicle center lymphoma¤Î°ìÎã- ÈéÉæ¤«¤é¤Î¿ÊŸÎã?Ž£ ÈØÅÄ»ÔΩÁí¹çɱ¡ÉÂÍý¡¡Ã«²¬½ñɧ--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«? 7.Ž¢¼«Á³ÇËÎö¤¬µ¿¤ï¤ì¤¿20ºÐÂåÃËÀ¤Îmulticystic nephroma(multilobular cystic nephroma, multilocular cyst)¤Î˶¸¡Î㎣¡¡ÀŲ¬ÆüÀÖɱ¡¡¡ÉÂÍýÉô¡¡³Þ¸¶ÀµÃË--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«? 8.Ž¢¥¯¥í¥¦¡¦¥Õ¥«¥»¡¡Crow-Fukase¾É¸õ·²(POEMS¾É¸õ·², ¹â·îÉÂ)¤Î°ìÎ㎣¡¡Ë¶¶»Ô̱ɱ¡¡¡Î×¾²ÉÂÍý²Ê¡¡Á°Â¿¾¾´î--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 9.Ž¢°ß´â¡¦ÇÙ¹â·ì°µ¾É¤Î˶¸¡Î㎣¡¡É;¾°åÂçÂèÆóÉÂÍý¡¡¾®¿ù°Ë»°É×--->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«? Êó¹ð Ž¢Ê¿À®20ǯÅÙÀŲ¬¸©Î×¾²¸¡ººÀºÅÙ´ÉÍýÄ´ºº¡¡ÉÂÍý¸¡ººÌȱÖÀ÷¿§¥µ¡¼¥Ù¥¤¤Ë´Ø¤¹¤ë½¸·×¡¦²òÀÏ·ë²ÌŽ£ ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡Î×¾²¸¡ºº²Ê¡¡·ªÅÄ¡¡¾¼ ER, PgRÀ÷¿§·ë²ÌVirtual Slide¤ò¸«¤ë Âè221²óÀŲ¬ÉÂÍý°å²ñ(SPS) †Âè221²ó¤ÏSPS¡¦¾ëÆîÉÂÍý½¸Ã̲ñ¤È¤Ê¤ê¤Þ¤¹¡£¡¡2008ǯ9·î27Æü(ÅÚ) ¾¼ÏÂÂç³ØÉ±¡Î×¾²¹ÖƲ¡¡¡Ê¾¼ÏÂÂç³ØÉ±¡Æþ±¡ÅïÃϲ¼£±³¬¡Ë--> SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø Âè220²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2008ǯ6·î21ÆüÉ;¾»ÔÉ;¾¤Þ¤Á¤Å¤¯¤ê¥»¥ó¥¿¡¼ 1.¡Ö°ß´â¤Ëʸ¤·¤¿¥ê¥ó¥ÑÁý¿£ÀÉÂÊÑ¡×À»ÎìÉ;¾É±¡¡¡¹¾²Ïͦ¼ù¡¢À¶¿å ¿Ê°ì---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 2.¡ÖÂ軰Ǿ¼¼²¼Éôǹ˦À¼ðáî¡×ÀŲ¬¸©Î©¤³¤É¤âɱ¡¡¡¹â¾ì·ÃÈþ¡¢Éͺê Ë---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 3.¡Öç´Ç´Ëì²¼¼ðáç--ç´È¯À¸¤ÎGIST¡×ÀŲ¬»ÔΩÀجɱ¡ ¿¹ÌÚÍø¾¼---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 4.¡Ö±¦Æð¸ý³¸¼ðáç¤Î°ìÎã¡×ÀŲ¬¸©Î©ÀŲ¬¤¬¤ó¥»¥ó¥¿¡¼¡¡Á𿼸ø½¨---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 5.¡ÖIntervention ¸å¤ËȯÀ¸¤·¤¿¿´¶Ú¾É¤Î£±Ë¶¸¡Îã¡¢£·£´ºÐÃËÀ¡×ÀŲ¬¸©Î©Áí¹çɱ¡¡¡¼¼¡¡ÇîÇ·¡¢ÎëÌÚ¡¡À¿¡¢¿·°æ°ì¼é---->Î×¾²»ö¹à¡¦¾ÉÎã²òÀâ? 6.¡Ö±¦Â¦Ê¢ÊÉ¡¢¾åÉô¸åÊ¢Ëì¡¢¹üÈ׹Ф«¤éÊ¢¹Ð¤Ë¸ºß¤¹¤ëµðÂç¼ðáç¤Î£³¾ÉÎã¡×ÀŲ¬ÀÖ½½»úɱ¡¡¡³Þ¸¶ÀµÃË---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 7.¡Ö²¼¿âÂμðáç¤Î£±Îã¡×É;¾°å²ÊÂç³ØÉí°É±¡¡¡ÌÚ²¼¿¿Æà---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« 8.¡ÖÂ軰Ǿ¼¼¼ðáç¤Î£±Îã¡×É;¾°å²ÊÂç³ØÉí°É±¡¡¡Ìܹõ»Ë¿¥---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« Âè219²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2008ǯ3·î22ÆüÀŲ¬»Ô¤¢¤¶¤ì¤¢¤Ç³«ºÅ. ²ñ½ªÎ»¸å,É;¾°åÂçÂèÆóÉÂÍýÅû°æÀèÀ¸¤ÎÂà´±µÇ°º©¿Æ²ñ@Éâ·îϰ £±¡¥°ß´âÆù¼ð¤Î°ìÎã¡¡É;¾°åÂçɱ¡ÉÂÍýÉô¡¡Ìܹõ»Ë¿¥Â¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« £²¡¥¿ÇÃǤ˶ìθ¤·¤¿À®¿Í½÷À¦ƬÍÕǾ¼ðáç¤Î°ìÎã¡¡¡¡ÀŲ¬´â¥»¥ó¥¿ÉÂÍý¿ÇÃDzʡ¡ÅÏî´Îï»Ò---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«? £³¡¥Å¾°Ü¤«¸¶È¯¤«¤¬ÌäÂê¤È¤Ê¤Ã¤¿83ºÐ½÷À,ÍñÁã¼ðáç¡¡ÀŲ¬´â¥»¥ó¥¿ÉÂÍý¿ÇÃDzʡ¡ÅÏî´Îï»Ò---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«? ÆÃÊ̵ǰ¹Ö±é¡¡É;¾°åÂçÂèÆóÉÂÍý¶µ¼ø¡¡Åû°æ¡¡¾ÍÇî¡¡ £´¡¥º¸³Ü²¼ÀþÉô¼ðáç¤Î°ìÎã¡¡ÀŲ¬´â¥»¥ó¥¿ÉÂÍý¿ÇÃDzʡ¡Á𿼸ø½¨Â¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« £µ¡¥½ÑÁ°TAE¤ò»Ü¹Ô¤·¤¿»éËÃÍÍ·ì´É³°Èé¼ð¤Î°ìÎã¡¡ÀŲ¬ÀÖ½½»úɱ¡ÉÂÍý¡¡³Þ¸¶¡¡ÀµÃË---->¾ÉÎã²òÀâ? £¶¡¥±ó°Ì·¿¥ß¥ª¥Ñ¥·¡¼¤Î°ì˶¸¡Îã¡¡É;¾°åÂçɱ¡ÉÂÍýÉô¡¡ÌÚ²¼¿¿Æà¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« Âè218²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2008ǯ1·î26ÆüÉ;¾»ÔÃϰè¾ðÊ󥻥󥿤dz«ºÅ. ²ñ½ªÎ»¸å¿·Ç¯²ñ¡÷¤¢¤ó¤É¤ê¤å¡¼¤¹Äâ £±¡¥EBVÍÛÀ¤ò¼¨¤·¤¿ÇÙ·ëÀáÀÉÂÊѤÎ1Îã¡¡É;¾°åÂçÂèÆóÉÂÍý¡¡¿·°æµÁʸ¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸«? £²¡¥±¦Äǹüư̮²òÎ¥Àư̮ÇËÎö¤Î1˶¸¡Îã¡¡ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡Ã«²¬½ñɧ¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« £³¡¥¿´Ëì°À¼ðáç¤Î˶¸¡Îã¡¡ÀŲ¬»ÔΩɱ¡¡¡¿¹ÌÚÍø¾¼---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« £´¡¥µÞÀ²õ»àÀ¹¥»ÀµåÀ¿´¶Ú±ê¤Î1Îã¡¡À»ÎìÉ;¾É±¡¡¡Âç·î´²ÏºÂ¾---->Î×¾²»ö¹à¡¦ÁÈ¿¥½ê¸« £µ¡¥ÈéÉæÂå¼ÕÀ¼À´µ¤Î2Îã¤ÈÈéÉæ±ê¾ÉÀ¼À´µ¤Î1Îã¡¡ÀŲ¬ÀÖ½½»úɱ¡¡¡³Þ¸¶ÀµÃË--->¾ÉÎã²òÀâ? £¶¡¥ÈéÉæÈóÄê·¿À¹³»À¶Ý¾É¤Î1Îã¡¡ÀŲ¬¸©Î©Áí¹çɱ¡¡¡¼¼ÇîÇ·--->¾ÉÎã²òÀâ Âè217²óÀŲ¬ÉÂÍý°å²ñ(SPS) †Âè217²óSPS¤ÏSPS-¾ëÆîÉÂÍý¹çƱ½¸Ã̲ñ¤È¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£¡¡2007ǯ9·î29Æü(ÅÚ)--> SPS-¾ëÆîÉÂÍý½¸Ã̲ñ¤Î¥Ú¡¼¥¸¤Ø Âè216²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2007ǯ4·î14ÆüÀŲ¬»Ô¤¢¤¶¤ì¤¢¤Ç³«ºÅ. ²ñ½ªÎ»¸åÉâ·îϰ¤ÇÉͺêÀèÀ¸¤Î°ÖÏ«²ñ
¹Ö±é ºÂĹ¡§»°±º¹îÉÒ¡¡¡ÊÉ;¾°åÂç´ðÁôǸî¡Ë Ž¢2005ǯ²þƤGleasonʬÎà¤ÈÌ©Éõ¾®Àþ¸»¤Ë¤è¤ëÁ°Î©Á£´âÆâ¾È¼ÍÎÅË¡Ž£¡¡¼¼ÇîÇ·(ÀŲ¬¸©Î©Áí¹çɱ¡¡Ë Ž¢¿À·Ð²ê¼ð¤Î¿ÍÍÀŽ£¡¡ÉͺêË(ÀŲ¬¸©Î©¤³¤É¤âɱ¡¡Ë Âè215²óÀŲ¬ÉÂÍý°å²ñ(SPS) †2007ǯ1·î13Æü(ÅÚ)É;¾¥¢¥¯¥È¸¦½¤¸òή¥»¥ó¥¿¡¼¤Ç³«ºÅ¡£¤½¤Î¸åº©¿Æ²ñ
Web¥Ö¥é¥¦¥¶(Firefox, sleipnir,Internet Explorer¤Ê¤É¡Ë¤ÇÀŲ¬ÉÂÍý°å²ñ¤ÎVS¤ò¸«¤ëÊýË¡ †SPS¤ÎVirtual slide¤ò¸«¤ë===>ÈØÅÄVS¥µ¡¼¥Ð''
Virtual Slide viewer soft¤Îinstall--->¤³¤Á¤é ¡ù¤³¤ì°Ê²¼¤Î²èÁü¤Ï±ÜÍ÷¥½¥Õ¥È¥¤¥ó¥¹¥È¡¼¥ë¸å¤ÎÁàºîÀâÌÀ¤Ç¤¹ Ž¢Browse Images Ž£¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£ ¥µ¡¼¥Ð¼ýǼ¥Õ¥¡¥¤¥ë°ìÍ÷¤Ç¤¹SPS¥Õ¥¡¥¤¥ë¤òÁªÂò¥¯¥ê¥Ã¥¯¤ÇSPS¥¹¥é¥¤¥É°ìÍ÷¤¬¤Ç¤Þ¤¹¡£ Virtual slide¤Î±ÜÍ÷¤¬½ªÎ»¤·¤¿¤é±¦¾å¤Î¥Ü¥¿¥ó¤Çsign out¤·¤Æ¤¯¤À¤µ¤¤ SPS¾ÉÎã¥ô¥¡¡¼¥Á¥ã¥ë¥¹¥é¥¤¥É¥Ç¡¼¥¿¥Ù¡¼¥¹²½¤Ø¤ÎÄó°Æ¤È¤ª´ê¤¤ †ÀŲ¬ÉÂÍý°å²ñ²ñ°÷³Æ°Ì ÀèÆü¤ÎSPS¤Ç¤Ï¿¿ô¤Î¾ÉÎã¤Ë¤Ä¤¤¤ÆÊÙ¶¯¤µ¤»¤Æ¤¤¤¿¤À¤¤¢¤ê¤¬¤È¤¦¤´¤¶¤¤¤Þ¤·¤¿¡£ ËÜÆü¤ÏSPS¤Î¥¹¥é¥¤¥É¶¦Í¤Ë¤Ä¤¤¤ÆÄó°Æ¤È¤ª´ê¤¤¤ò¤¤¤¿¤·¤¿¤¯¡¢Ï¢Íí¤µ¤»¤Æ¤¤¤¿¤À¤¤Þ¤¹¡£ ºÇ¶á¡¢É;¾°åÂç¤ËÉ;¾¥Û¥È¥Ë¥¯¥¹¤Î¥ô¥¡¡¼¥Á¥ã¥ë¥¹¥é¥¤¥É¥·¥¹¥Æ¥à(°Ê²¼VSS)¤¬Æ³Æþ¤µ¤ì¤Þ¤·¤¿¡£¤³¤ì¤Ï¾Ë»Ò¥¹¥é¥¤¥É¤ÎɸËܤò¥Ç¥¸¥¿¥ë²èÁü²½¤·¤ÆÊݸ¤·ÉÕ°¤Îviewer¥½¥Õ¥È¤Ë¤è¤ê¥Ñ¥½¥³¥ó¥â¥Ë¥¿¤Ç¸¡¶À²Äǽ¤Ë¤¹¤ëÁõÃ֤Ǥ¹¡£¥ë¡¼¥ÚÁü¤«¤é¸÷¸²¤Î40ÇܤޤÇÄ̾ï¤Î¸²Èù¶À¤È½¿§¤Î¤Ê¤¤¥¯¥ª¥ê¥Æ¥£¤Ç±ÜÍ÷¤¬¤Ç¤¤Þ¤¹¡£viewer¥½¥Õ¥È¤Ï̵ÎÁ¤ÇÇÛÉۤǤ¤Þ¤¹¡£¡ÊAdobe¤Îacrobat¤ÎÊý¼°¡Ë
¤³¤ÎÁõÃÖ¤ò»È¤Ã¤Æ¡¢ÀèÆü¤Î215²óSPS¾ÉÎ㥹¥é¥¤¥ÉɸËܤò¥Ç¥¸¥¿¥ë²½¤·²ñ°÷³Æ°Ì¤ËÇÛÉÛ¤·¤¿¤¤¤È¹Í¤¨¤Þ¤¹¡£¤´»¿Æ±¤¤¤¿¤À¤±¤ëÊý¤Ï¾ÉÎã¤ÎHE¥¹¥é¥¤¥É¤ò£±Ëç벬°¸¤ËÆÏ¤±¤ÆÄº¤±¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£¸Ä¿Í¾ðÊó¤Ë¤Ä¤¤¤Æ¤ÏÉÂÍý³Ø²ñ¤Î»Ø¿Ë¤ò½å¼é¤·¤Þ¤¹¡£ ¥¹¥é¥¤¥É¤Î¶¦Í²½¤Ë¤Ï3¼ïÎà¤ÎÊýË¡¤ò¹Í¤¨¤Æ¤¤¤Þ¤¹¡£
£±¡¥¤ÎÊý¼°¤Ë¤Ä¤¤¤Æ¤Ï²èÁü¥Õ¥¡¥¤¥ë¤Î¥Ç¡¼¥¿¤¬µðÂç¤Ê¤¿¤á¥µ¡¼¥Ð¤«¤éľÀÜ¥À¥¦¥ó¥í¡¼¥É¤¹¤ë¤ÈÉé²Ù¤¬¤«¤«¤ê¤¹¤®¤Þ¤¹¡£¤½¤Î¤¿¤áP2P(¥Ô¥¢¥Ä¡¼¥Ô¥¢)¥½¥Õ¥È¤ò»ÈÍѤ·¤Þ¤¹¡£P2P¥½¥Õ¥È¤ÏWinny¤Ç°Ì¾¹â¤¯¡©¤Ê¤Ã¤Æ¤·¤Þ¤¤¤Þ¤·¤¿¤¬ËÜÍè¤ÏÂ礤ʥե¡¥¤¥ë¤Î¥Ç¡¼¥¿¤òÇÛÉÛ¤¹¤ë¤¿¤á¤ËÍÍѤʥ½¥Õ¥È¤Ç¤¹¡£Linux¤ÎÀ¤³¦¤Ç¤ÏOS¤ÎÇÛÉÛ¤ËÄ̾ï»ÈÍѤµ¤ì¤Æ¤ª¤ê¹çË¡¤Ê¥Ç¡¼¥¿¤Î¤ß¥À¥¦¥ó¥í¡¼¥É¤¹¤ì¤Ð°ÂÁ´¤Ç¤¹¡£º£²ó¤Ï¥Õ¥ê¡¼¥½¥Õ¥È¤ÎbitTorrent¤ò»È¤¤¤Þ¤¹¡£ bitTorrent¤ÏµðÂç¤Ê¥Õ¥¡¥¤¥ë¤ò¹â®¤Ë¥À¥¦¥ó¥í¡¼¥É¤¹¤ë¤³¤È¤òÌÜŪ¤Ë³«È¯¤µ¤ì¤¿P2P¥¯¥é¥¤¥¢¥ó¥È¥½¥Õ¥È¡£ ¾¤Î¿¤¯¤ÎP2P¥Õ¥¡¥¤¥ë¶¦Í¥½¥Õ¥È¥¦¥§¥¢¤È°Û¤Ê¤ê¡¢BitTorrent?¤ÏÈóƿ̾¤ÎP2P¥Í¥Ã¥È¥ï¡¼¥¯¤Ç¤¹¡£ Èóƿ̾¤Î¤¿¤á°ãË¡¥Õ¥¡¥¤¥ë¶¦Í¤Ê¤É¤Ø¤Î°ÍѤòËɤ®¤Ä¤Ä¡¢¥¤¥ó¥¿¡¼¥Í¥Ã¥È¾å¤Î»ñ¸»¤ò͸úÍøÍѤ·¤ÆµðÂç¤Ê¥¢¥×¥ê¥±¡¼¥·¥ç¥ó¤ä¥Þ¥ë¥Á¥á¥Ç¥£¥¢¥Õ¥¡¥¤¥ë¤ÎÇÛÉÕ¤¬²Äǽ¤Ç¤¹ ¥Õ¥ê¡¼¤Î¥½¥Õ¥È¤Ç¤ÏbitComet¤ÈAzreus¤¬Í̾¤Ç¤¹¡¥windows¤Ç¤ÏbitCommet¤¬Â¿ÍѤµ¤ì¤Æ¤¤¤ë¤è¤¦¤Ç¤¹ £²¡¥¤Ë¤Ä¤¤¤Æ¤Ï½ãÀµÉʤΥµ¡¼¥ÐÇÛÉÛ¥½¥Õ¥È»ÈÍÑÎÁ¤¬10Ëü±ß/·î¤È¹â²Á¤Ê¤¿¤áƳÆþ¤·¤Æ¤¤¤Þ¤»¤ó¡£¤³¤ì¤¬¤¢¤ì¤Ð¥¦¥¨¥Ã¥Ö¤«¤é±ÜÍ÷¤Ç¤¤Þ¤¹¤¬¸½ºß¤Ï̵Íý¤Ç¤¹¡£º£±ÜÍ÷ÊýË¡¤Î¼Â¸³¤ò¤·¤Æ¤¤¤Þ¤¹¡£¤¦¤Þ¤¯¤¤¤±¤Ð¤ª¶â¤¬¤«¤«¤é¤º¤Ë¥¤¥ó¥¿¡¼¥Í¥Ã¥È¾å¤Ç±ÜÍ÷¤Ç¤¤ë¤è¤¦¤Ë¤Ê¤ë¤«¤â¤·¤ì¤Þ¤»¤ó¡£±ÜÍ÷¤Ë¤ÏÀ©¸Â¤ò¤·¤ÆÉô³°¼Ô¤ÎÀܳ¤òÀ©¸Â¤·¤Æ¤¤¤Þ¤¹¡£ £³.°ì²ó¤Î¥Õ¥¡¥¤¥ë¥Ç¡¼¥¿¤ÏDVD1-2Ëç¤Ë¼ý¤Þ¤ë¤È»×¤¤¤Þ¤¹¡£DVDÂå¤È͹Á÷ÎÁ¤¬¤«¤«¤ê¤Þ¤¹¤¬ºÇ¤â¥ª¡¼¥½¥É¥Ã¥¯¥¹¤ÊÊýË¡¤Ç¤¹¡£ °ÊÁ°¤è¤ê¡¢SPS¤Îµ®½Å¤Ê¾ÉÎã¤Î¥¹¥é¥¤¥É¤ò¶¦Í¤·¤Æ¤¤¤Ä¤Ç¤â¸«ÊÖ¤·¤¬¤Ç¤¤Ê¤¤¤«¤È¹Í¤¨¤Æ¤ª¤ê¤Þ¤·¤¿¡£ÃæÉô¸ò¸«²ñ¤â¤½¤¦¤Ç¤¹¤¬²¿Ëç¤â¥¹¥é¥¤¥É¤òºî¤ë¤Î¤ÏÂçÊѤǤ¹¡£VSS¤Ê¤é¿ÇÃǤËÍѤ¤¤¿¥ª¥ê¥¸¥Ê¥ë¤ÎHE¥¹¥é¥¤¥É¤ò°ìËç¤ò¥Ç¥¸¥¿¥ë²½¤·¤Æ¤ª¤±¤ÐÁ´°÷¤Ç¶¦Í²Äǽ¤Ë¤Ê¤ê¡¢Îô²½¤»¤º¤¤¤Ä¤Ç¤â±ÜÍ÷¤¬¤Ç¤¤ë¤è¤¦¤Ë¤Ê¤ê¤Þ¤¹¡£
°Ê¾åѨ±Û¤Ç¤Ï¤¢¤ê¤Þ¤¹¤¬¡¢µ¡´ï¤Î³«È¯¤Ë¿¾¯´Ø¤ï¤Ã¤¿±ï¤ÇSPS¤Î¥ô¥¡¡¼¥Á¥ã¥ë¥¹¥é¥¤¥É¶¦Í²½¤Ë¤Ä¤¤¤ÆÄ󰯤µ¤»¤ÆÄº¤¤Þ¤·¤¿¡£SPS¤ò¥¹¥é¥¤¥É¶¦Í¤ÎÀ®¸ùÎã¤Ë¤·¤¿¤¤¤È¶¯¤¯´ê¤Ã¤Æ¤ª¤ê¤Þ¤¹¡£
Wikipathologica-- ¤ß¤ó¤Ê¤Çºî¤ëÉÂÍý¥¢¥È¥é¥¹¤â¤´Í÷²¼¤µ¤¤¡£ ÈØÅÄ»ÔΩÁí¹çɱ¡¡¡Ã«²¬¡¡½ñɧ¡¡É;¾°åÂçÉÂÍý³ØÂè°ì¹ÖºÂ¡¡¿ú¼¡¡½Õɧ mail to wikipathologica@gmail.com |